Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 511 articles:
HTML format



Single Articles


    November 2021
  1. FILTS Y, Litman RE, Martinez J, Anta L, et al
    Long-term efficacy and safety of once-monthly Risperidone ISM(R) in the treatment of schizophrenia: Results from a 12-month open-label extension study.
    Schizophr Res. 2021;239:83-91.
    PubMed     Abstract available


  2. LEWIS DA, Dienel SJ, Chung DW
    Searching for the "final proof" of schizophrenia.
    Schizophr Res. 2021 Nov 26. pii: S0920-9964(21)00446.
    PubMed    


  3. ZHU X, Fan H, Zou Y, Tan Y, et al
    Computerized or manual? Long term effects of cognitive remediation on schizophrenia.
    Schizophr Res. 2021;239:47-54.
    PubMed     Abstract available


  4. JOHNSON KA, Shrier LA, Eiduson R, Parsa N, et al
    Depressive symptom screening and endorsement of psychosis risk-related experiences in a diverse adolescent and young adult outpatient clinic in the US.
    Schizophr Res. 2021 Nov 25. pii: S0920-9964(21)00447.
    PubMed     Abstract available


  5. CARPINIELLO B, Pinna F, Manchia M, Tusconi M, et al
    Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.
    Schizophr Res. 2021;239:34-41.
    PubMed     Abstract available


  6. MILLER BJ, McEvoy JP, McCall WV, Harris RA, et al
    Insomnia and triglycerides in schizophrenia.
    Schizophr Res. 2021;239:42-43.
    PubMed    


  7. SUHAS S, Rao NP
    Personal protective equipment in the emergency room and schizophrenia - Implications beyond safety.
    Schizophr Res. 2021;239:32-33.
    PubMed    


  8. OLUWOYE O, Stokes B
    The unique pathways to coordinate specialty care for Black families navigating early psychosis: A preliminary report.
    Schizophr Res. 2021 Nov 22. pii: S0920-9964(21)00425.
    PubMed     Abstract available


  9. LI Z, Zhang T, Xu L, Wei Y, et al
    Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis.
    Schizophr Res. 2021;239:19-28.
    PubMed     Abstract available


  10. CERNIS E, Molodynski A, Ehlers A, Freeman D, et al
    Dissociation in patients with non-affective psychosis: Prevalence, symptom associations, and maintenance factors.
    Schizophr Res. 2021;239:11-18.
    PubMed     Abstract available


  11. NASRALLAH HA
    To change the label of schizophrenia, first revise the construct.
    Schizophr Res. 2021;238:201-202.
    PubMed    


  12. SANDOVAL LR, Stone L, Guimond S, Lawler A, et al
    Encapsulating psychosis with a second language: A clinical case.
    Schizophr Res. 2021 Nov 17. pii: S0920-9964(21)00422.
    PubMed     Abstract available


  13. MOTA NB
    Commentary on "Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations": The current need for the harmonization of speech elicitation protocols in basic and applied science.
    Schizophr Res. 2021;238:199-200.
    PubMed    


  14. NASRALLAH HA
    Re-inventing the schizophrenia syndrome: The elusive "theory of everything".
    Schizophr Res. 2021 Nov 16. pii: S0920-9964(21)00427.
    PubMed    


  15. WADDINGTON JL, Nkire N, Russell V
    Schizophrenia vis-a-vis dimensional-spectrum concepts of psychotic illness: Has an answer been 'hiding in plain sight'?
    Schizophr Res. 2021 Nov 16. pii: S0920-9964(21)00433.
    PubMed    


  16. JOHNSON MC, Baum ML, Lizano P
    Falling through the cracks: Missed opportunities for diagnosing and treating lupus in schizophrenia.
    Schizophr Res. 2021;238:185-187.
    PubMed    


    October 2021
  17. OWEN MJ, Legge SE
    The nature of schizophrenia: As broad as it is long.
    Schizophr Res. 2021 Oct 28. pii: S0920-9964(21)00409.
    PubMed    


  18. SEABURY RD, Bearden CE, Ventura J, Subotnik KL, et al
    Confident memory errors and disrupted reality testing in early psychosis.
    Schizophr Res. 2021;238:170-177.
    PubMed     Abstract available


  19. MESHOLAM-GATELY RI, Varca N, Spitzer C, Parrish EM, et al
    Are we ready for a name change for schizophrenia? A survey of multiple stakeholders.
    Schizophr Res. 2021;238:152-160.
    PubMed     Abstract available


  20. LEATHEM LD, Currin DL, Montoya AK, Karlsgodt KH, et al
    Socioemotional mechanisms of loneliness in subclinical psychosis.
    Schizophr Res. 2021;238:145-151.
    PubMed     Abstract available


  21. KU BS, Addington J, Bearden CE, Cadenhead KS, et al
    Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium.
    Schizophr Res. 2021;238:137-144.
    PubMed     Abstract available


  22. CATALANO LT, Wynn JK, Lee J, Green MF, et al
    A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study.
    Schizophr Res. 2021;238:128-136.
    PubMed     Abstract available


  23. VOGEL JS, Bruins J, de Jong S, Knegtering H, et al
    Satisfaction with social connectedness as a predictor for positive and negative symptoms of psychosis: A PHAMOUS study.
    Schizophr Res. 2021;238:121-127.
    PubMed     Abstract available


  24. BASAVARAJU R, Ithal D, Thanki MV, Ramalingaiah AH, et al
    Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled trial.
    Schizophr Res. 2021;238:108-120.
    PubMed     Abstract available


  25. NARITA Z, Yang K, Kuga H, Piancharoen P, et al
    Face processing of social cognition in patients with first episode psychosis: Its deficits and association with the right subcallosal anterior cingulate cortex.
    Schizophr Res. 2021;238:99-107.
    PubMed     Abstract available


  26. TAN EJ, Meyer D, Neill E, Rossell SL, et al
    Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations.
    Schizophr Res. 2021;238:91-98.
    PubMed     Abstract available


  27. NORRA C, Ueberberg B, Juckel G
    A new electronically based clinical pathway for schizophrenia inpatients: A longitudinal pilot study.
    Schizophr Res. 2021;238:82-90.
    PubMed     Abstract available


  28. MCGRATH JJ, Wray NR
    Seven short reflections on the notion of schizophrenia.
    Schizophr Res. 2021 Oct 8. pii: S0920-9964(21)00396.
    PubMed    


  29. JOE P, Clemente JC, Piras E, Wallach DS, et al
    An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth.
    Schizophr Res. 2021 Oct 5. pii: S0920-9964(21)00389.
    PubMed     Abstract available


  30. PUTHOTA J, Alatorre A, Walsh S, Clemente JC, et al
    Prenatal ambient temperature and risk for schizophrenia.
    Schizophr Res. 2021 Oct 4. pii: S0920-9964(21)00390.
    PubMed     Abstract available


  31. FELDMAN J, Hamlyn A, Rice T
    Social media in screening and monitoring for early intervention in psychosis.
    Schizophr Res. 2021;238:70-72.
    PubMed    


  32. GOLAY P, Ramain J, Jenni R, Klauser P, et al
    Six months functional response to early psychosis intervention program best predicts outcome after three years.
    Schizophr Res. 2021;238:62-69.
    PubMed     Abstract available


  33. ESKRIDGE CLM, Hochberger WC, Kaseda ET, Lencer R, et al
    Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.
    Schizophr Res. 2021;236:54-60.
    PubMed     Abstract available


  34. KALIUZHNA M, Kirschner M, Carruzzo F, Hartmann-Riemer MN, et al
    How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain.
    Schizophr Res. 2021;236:41-47.
    PubMed     Abstract available


    September 2021
  35. KOSUGI N, Oshiyama C, Kodama N, Niwa SI, et al
    Predictability of a favorable outcome in schizophrenia associated with positive effects of "music therapy incorporated into cognitive remediation".
    Schizophr Res. 2021;238:52-53.
    PubMed    


  36. WOODBERRY KA, Powers KS, Bryant C, Downing D, et al
    Emotional and stigma-related experiences relative to being told one is at risk for psychosis.
    Schizophr Res. 2021;238:44-51.
    PubMed     Abstract available


  37. CHESNEY E, Robson D, Patel R, Shetty H, et al
    The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study.
    Schizophr Res. 2021;238:29-35.
    PubMed     Abstract available


  38. PAVITHRA A, Durairaj J, Raghavan V
    No association between advanced paternal age and age of onset of illness among patients with schizophrenia: A cross-sectional study from South India.
    Schizophr Res. 2021;238:27-28.
    PubMed    


  39. HAHN S, Moritz S, Elmers J, Scheunemann J, et al
    Do you like cliff-hangers? Objective versus subjective need for closure in the schizophrenia spectrum.
    Schizophr Res. 2021;238:20-26.
    PubMed     Abstract available


  40. TAKEUCHI H, Sanches M, Borlido C, Agid O, et al
    Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implications.
    Schizophr Res. 2021;237:202-207.
    PubMed     Abstract available


  41. LEE YJ, Huang SY, Lin CP, Tsai SJ, et al
    Alteration of power law scaling of spontaneous brain activity in schizophrenia.
    Schizophr Res. 2021;238:10-19.
    PubMed     Abstract available


  42. ROSEN C, Harrow M, Tong L, Jobe TH, et al
    A word is worth a thousand pictures: A 20-year comparative analysis of aberrant abstraction in schizophrenia, affective psychosis, and non-psychotic depression.
    Schizophr Res. 2021;238:1-9.
    PubMed     Abstract available


  43. OSPINA LH, Beck-Felts K, Ifrah C, Shagalow S, et al
    Relationships among inflammation, social cognition, and social functioning in schizophrenia.
    Schizophr Res. 2021 Sep 22. pii: S0920-9964(21)00362.
    PubMed    


  44. KRISTENSEN TD, Glenthoj LB, Ragahava JM, Syeda W, et al
    Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis.
    Schizophr Res. 2021;237:192-201.
    PubMed     Abstract available


  45. ESCOLA-GASCON A, Wright AC
    Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis?
    Schizophr Res. 2021;237:190-191.
    PubMed    


  46. SENGUTTA M, Karow A, Gaweda L
    Anomalous self-experiences (ASE) in relation to clinical high risk for psychosis (CHRP), childhood trauma and general psychopathology among adolescent and young adult help seekers.
    Schizophr Res. 2021;237:182-189.
    PubMed     Abstract available


  47. TAKAHASHI T, Sasabayashi D, Takayanagi Y, Furuichi A, et al
    Altered Heschl's gyrus duplication pattern in first-episode schizophrenia.
    Schizophr Res. 2021;237:174-181.
    PubMed     Abstract available


  48. CHEN YM, Chen HK, Wu BJ, Chen IC, et al
    Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia.
    Schizophr Res. 2021;237:166-173.
    PubMed     Abstract available


  49. MEHTA UM, Ibrahim FA, Sharma MS, Venkatasubramanian G, et al
    Resting-state functional connectivity predictors of treatment response in schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;237:153-165.
    PubMed     Abstract available


  50. FOX V, Sheffield JM, Woodward ND
    Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms.
    Schizophr Res. 2021;237:141-147.
    PubMed     Abstract available


  51. SUETANI S, Honarparvar F, Siskind D, Hindley G, et al
    Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls.
    Schizophr Res. 2021;237:131-140.
    PubMed     Abstract available


  52. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Lorente-Omenaca R, et al
    A network analysis and empirical validation of executive deficits in patients with psychosis and their healthy siblings.
    Schizophr Res. 2021;237:122-130.
    PubMed     Abstract available


  53. ROKITA KI, Dauvermann MR, Mothersill D, Holleran L, et al
    Current psychosocial stress, childhood trauma and cognition in patients with schizophrenia and healthy participants.
    Schizophr Res. 2021;237:115-121.
    PubMed     Abstract available


  54. TAO TJ, Hui CLM, Lam BST, Ho ECN, et al
    Mindfulness meditation for Chinese patients with psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2021;237:103-114.
    PubMed     Abstract available


  55. PAREDES R, Ferri F, Series P
    Influence of E/I balance and pruning in peri-personal space differences in schizophrenia: A computational approach.
    Schizophr Res. 2021 Sep 8. pii: S0920-9964(21)00238.
    PubMed     Abstract available


  56. SHIMOMURA Y, Kikuchi Y, Suzuki T, Uchida H, et al
    Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms.
    Schizophr Res. 2021;236:142-155.
    PubMed     Abstract available


  57. POLARI A, Street R, Conus P, Finkelstein A, et al
    Patients', carers' and clinicians' attitudes towards alternative terms to describe the at-risk for psychosis state.
    Schizophr Res. 2021;237:69-75.
    PubMed     Abstract available


  58. LURIE I, Shoval G, Hoshen M, Balicer R, et al
    The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study.
    Schizophr Res. 2021;237:62-68.
    PubMed     Abstract available


  59. O'DRISCOLL C, Shaikh M, Finamore C, Platt B, et al
    Profiles and trajectories of mental health service utilisation during early intervention in psychosis.
    Schizophr Res. 2021;237:47-53.
    PubMed     Abstract available


  60. MOLINA JL, Joshi YB, Nungaray JA, Thomas ML, et al
    Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training.
    Schizophr Res. 2021;236:135-141.
    PubMed     Abstract available


  61. SEPPALA A, Pylvanainen J, Lehtiniemi H, Hirvonen N, et al
    Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;236:123-134.
    PubMed     Abstract available


  62. VAN DUIN D, de Winter L, Kroon H, Veling W, et al
    Effects of IPS plus cognitive remediation in early psychosis: 18-month functioning outcomes of a randomized controlled trial.
    Schizophr Res. 2021;236:115-122.
    PubMed     Abstract available


  63. GUPTA L, Hoffman KW
    Exploring the intersection of the microbiome and the developing brain: Impacts on schizophrenia risk.
    Schizophr Res. 2021 Sep 2. pii: S0920-9964(21)00325.
    PubMed     Abstract available


  64. ROSA PGP, Zugman A, Cerqueira CT, Serpa MH, et al
    Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification.
    Schizophr Res. 2021;236:104-114.
    PubMed     Abstract available


  65. AMORETTI S, Rabelo-da-Ponte FD, Rosa AR, Mezquida G, et al
    Cognitive clusters in first-episode psychosis.
    Schizophr Res. 2021;237:31-39.
    PubMed     Abstract available


  66. PATIL AN, Kasudhan KS, Naveen M, Batra GK, et al
    Precise pharmacogenetic pharmacometabolomic (PPP) guided clozapine therapy in treatment resistant schizophrenia: Insights from one ethnicity experiment.
    Schizophr Res. 2021;237:26-28.
    PubMed    


  67. ZHU Y, Zhang C, Siafis S, Zhuo K, et al
    Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis.
    Schizophr Res. 2021;237:20-25.
    PubMed     Abstract available


  68. MAGUIRE PA, Reay RE, Looi JCL
    H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care.
    Schizophr Res. 2021;237:101-102.
    PubMed    


    August 2021
  69. TANG CH, Ramcharran D, Yang CW, Chang CC, et al
    A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan.
    Schizophr Res. 2021;237:9-19.
    PubMed     Abstract available


  70. GIN K, Stewart C, Abbott C, Banerjea P, et al
    Psychosocial predictors of distressing unusual experiences in adolescence: Testing the fit of an adult cognitive model of psychosis.
    Schizophr Res. 2021;237:1-8.
    PubMed     Abstract available


  71. GIRARD JM, Vail AK, Liebenthal E, Brown K, et al
    Computational analysis of spoken language in acute psychosis and mania.
    Schizophr Res. 2021 Aug 26. pii: S0920-9964(21)00252.
    PubMed     Abstract available


  72. DE JAGER J, Topper M, Nugter A, van Os J, et al
    The impact of childhood sexual trauma on intimacy and sexuality needs among people with non-affective psychosis.
    Schizophr Res. 2021;236:97-103.
    PubMed     Abstract available


  73. IHLER HM, Lagerberg TV, Lyngstad SH, Melle I, et al
    Exploring the relationship between recency and frequency of cannabis use and diminished expression and apathy as two dimensions of negative symptoms in first episode psychosis. A one-year follow-up study.
    Schizophr Res. 2021;236:89-96.
    PubMed     Abstract available


  74. SANTESTEBAN-ECHARRI O, Liu L, Cadenhead KS, Tsuang MT, et al
    Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up.
    Schizophr Res. 2021;236:87-88.
    PubMed    


  75. MILLER ML, Strassnig MT, Bromet E, Depp CA, et al
    Performance-based assessment of social skills in a large sample of participants with schizophrenia, bipolar disorder and healthy controls: Correlates of social competence and social appropriateness.
    Schizophr Res. 2021;236:80-86.
    PubMed     Abstract available


  76. FERRARO L, La Cascia C, La Barbera D, Sanchez-Gutierrez T, et al
    The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.
    Schizophr Res. 2021;236:69-79.
    PubMed     Abstract available


  77. ERICKSON MA, Hahn B, Kiat JE, Alliende LM, et al
    Neural basis of the visual working memory deficit in schizophrenia: Merging evidence from fMRI and EEG.
    Schizophr Res. 2021;236:61-68.
    PubMed     Abstract available


  78. VAN DER HEIJDEN HS, Schirmbeck F, McGuire P, Valmaggia LR, et al
    Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study.
    Schizophr Res. 2021;236:48-53.
    PubMed     Abstract available


  79. GROVER S, Kathiravan S, Suman A, Naskar C, et al
    Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India.
    Schizophr Res. 2021;236:38-40.
    PubMed    


  80. WANG Y, Jiang Y, Collin G, Liu D, et al
    The effects of antipsychotics on interactions of dynamic functional connectivity in the triple-network in first episode schizophrenia.
    Schizophr Res. 2021;236:29-37.
    PubMed     Abstract available


  81. GONZALEZ-BLANCO L, Garcia-Portilla MP, Gutierrez M, Mezquida G, et al
    Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
    Schizophr Res. 2021;236:19-28.
    PubMed     Abstract available


  82. LUNSFORD-AVERY JR, Pelletier-Baldelli A, Korenic SA, Schiffman J, et al
    Eveningness chronotype preference among individuals at clinical high risk for psychosis.
    Schizophr Res. 2021;236:3-8.
    PubMed     Abstract available


  83. DESTE G, Vita A, Nibbio G, Barlati S, et al
    Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features.
    Schizophr Res. 2021;236:12-18.
    PubMed     Abstract available


  84. KLEIN-PETERSEN AW, Kohler-Forsberg O, Benros ME
    Infections, antibiotic treatment and the Microbiome in relation to schizophrenia.
    Schizophr Res. 2021;234:71-77.
    PubMed     Abstract available


  85. NGUYEN TT, Hathaway H, Kosciolek T, Knight R, et al
    Gut microbiome in serious mental illnesses: A systematic review and critical evaluation.
    Schizophr Res. 2021;234:24-40.
    PubMed     Abstract available


    July 2021
  86. DEL RE EC, Tan EJ
    Let's talk about researchers: A SIRS roundtable on mental health among schizophrenia researchers.
    Schizophr Res. 2021;235:63-64.
    PubMed    


  87. IRURETAGOYENA B, Castaneda CP, Mena C, Diaz C, et al
    Predictors of clozapine discontinuation at 2years in treatment-resistant schizophrenia.
    Schizophr Res. 2021;235:102-108.
    PubMed     Abstract available


  88. MACDONALD KI, Spilka MJ, Bartolomeo LA, Raugh IM, et al
    Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis.
    Schizophr Res. 2021 Jul 29. pii: S0920-9964(21)00283.
    PubMed    


  89. HALVERSON TF, Meyer-Kalos PS, Perkins DO, Gaylord SA, et al
    Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT).
    Schizophr Res. 2021;235:91-101.
    PubMed     Abstract available


  90. LINKE M, Jankowski KS
    Chronotype in individuals with schizophrenia: A meta-analysis.
    Schizophr Res. 2021;235:74-79.
    PubMed     Abstract available


  91. SANTO-ANGLES A, Salvador R, Gomar JJ, Guerrero-Pedraza A, et al
    Interindividual variability of functional connectome in schizophrenia.
    Schizophr Res. 2021;235:65-73.
    PubMed     Abstract available


  92. GROVER S, Keshavan MS, Lizano PL, Reinhart RMG, et al
    Proximate markers of cognitive dysfunction in schizophrenia.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00272.
    PubMed    


  93. HANSEN MC, Lynch DA, Stefancic A, Medalia A, et al
    Metamotivation in people diagnosed with schizophrenia: A conceptual introduction and qualitative study.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00215.
    PubMed     Abstract available


  94. PRASAD KM
    Infectious agents as risk factors for psychosis - A time to reconsider and reinvigorate investigations.
    Schizophr Res. 2021 Jul 26. pii: S0920-9964(21)00259.
    PubMed    


  95. WANG YC, Chen CH, Chen SJ, Cheng FY, et al
    Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing.
    Schizophr Res. 2021;235:60-62.
    PubMed    


  96. HIGUCHI CH, Cogo-Moreira H, Fonseca L, Ortiz BB, et al
    Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging.
    Schizophr Res. 2021 Jul 22. pii: S0920-9964(21)00249.
    PubMed     Abstract available


  97. BULUBAS L, Goerigk S, Gomes JS, Brem AK, et al
    Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial.
    Schizophr Res. 2021;235:44-51.
    PubMed     Abstract available


  98. DLAGNEKOVA A, van Staden W, Masenge A
    Validity and reliability of the Vigour Assessment Scale in avolitional schizophrenia outpatients.
    Schizophr Res. 2021;235:36-43.
    PubMed     Abstract available


  99. GROVER S, Naskar C, Sahoo S, Mehra A, et al
    Starting clozapine in patients with schizophrenia during the ongoing pandemic.
    Schizophr Res. 2021 Jul 21. pii: S0920-9964(21)00257.
    PubMed    


  100. STROMME MF, Mellesdal LS, Bartz-Johannesen C, Kroken RA, et al
    Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study.
    Schizophr Res. 2021;235:29-35.
    PubMed     Abstract available


  101. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: Findings of dose-response analysis from a pilot randomized controlled trial.
    Schizophr Res. 2021 Jul 20. pii: S0920-9964(21)00268.
    PubMed    


  102. TENDILLA-BELTRAN H, Coatl-Cuaya H, Meneses-Prado S, Vazquez-Roque RA, et al
    Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats.
    Schizophr Res. 2021;235:17-28.
    PubMed     Abstract available


  103. ZHAO Y, Wen SW, Qin Y, Liu Y, et al
    Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism.
    Schizophr Res. 2021;235:12-16.
    PubMed     Abstract available


  104. YANG K, Hua J, Etyemez S, Paez A, et al
    Volumetric alteration of olfactory bulb and immune-related molecular changes in olfactory epithelium in first episode psychosis patients.
    Schizophr Res. 2021;235:9-11.
    PubMed    


  105. CARRION RE, Auther AM, McLaughlin D, Cornblatt BA, et al
    The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study.
    Schizophr Res. 2021;236:9-11.
    PubMed    


  106. KREIS I, Zhang L, Moritz S, Pfuhl G, et al
    Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00246.
    PubMed     Abstract available


  107. KOHLER-FORSBERG O, Madsen T, Behrendt-Moller I, Nordentoft M, et al
    The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort.
    Schizophr Res. 2021 Jul 13. pii: S0920-9964(21)00245.
    PubMed     Abstract available


  108. YOON JH, Maddock RJ, Laufer J, Minzenberg MJ, et al
    Absence of altered in vivo concentration of dorsolateral prefrontal cortex GABA in recent onset schizophrenia.
    Schizophr Res. 2021 Jul 9. pii: S0920-9964(21)00230.
    PubMed    


  109. BROWNE J, Mohamed S
    Evaluation of disparities in impact of mental health intensive case management on 6-month symptoms, functioning, and quality of life between black and white veterans diagnosed with schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00255.
    PubMed     Abstract available


  110. ALBINANA C, Boelt SG, Cohen AS, Zhu Z, et al
    Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia.
    Schizophr Res. 2021 Jul 8. pii: S0920-9964(21)00216.
    PubMed     Abstract available


  111. XI YB, Guo F, Liu WM, Fu YF, et al
    Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging.
    Schizophr Res. 2021;233:89-96.
    PubMed     Abstract available


  112. DE CATES AN, Catone G, Marwaha S, Bebbington P, et al
    Self-harm, suicidal ideation, and the positive symptoms of psychosis: Cross-sectional and prospective data from a national household survey.
    Schizophr Res. 2021;233:80-88.
    PubMed     Abstract available


  113. KHACHADOURIAN V, Zaks N, Lin E, Reichenberg A, et al
    Advanced paternal age and risk of schizophrenia in offspring - Review of epidemiological findings and potential mechanisms.
    Schizophr Res. 2021;233:72-79.
    PubMed     Abstract available


  114. POOLE-WRIGHT K, Gaughran F, Murray R, Chalder T, et al
    Fatigue in psychosis.
    Schizophr Res. 2021 Jul 6. pii: S0920-9964(21)00244.
    PubMed    


  115. GROSSMAN MJ, Bowie CR
    Money talks: The influence of extrinsic motivators on social cognition in early episode psychosis.
    Schizophr Res. 2021;233:52-59.
    PubMed     Abstract available


  116. HOY KE, Coyle H, Gainsford K, Hill AT, et al
    Investigating neurophysiological markers of impaired cognition in schizophrenia.
    Schizophr Res. 2021;233:34-43.
    PubMed     Abstract available


  117. O'DONOGHUE B, Castagnini E, Langstone A, Mifsud N, et al
    Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.
    Schizophr Res. 2021;233:31-33.
    PubMed    


  118. BURKHARDT E, Berger M, Yolken RH, Lin A, et al
    Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Schizophr Res. 2021;233:24-30.
    PubMed     Abstract available


  119. SALGADO-PINEDA P, Fuentes-Claramonte P, Spanlang B, Pomes A, et al
    Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the 'enfacement' paradigm.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00243.
    PubMed     Abstract available


  120. IGATA R, Tesen H, Konishi Y, Ikenouchi A, et al
    Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00253.
    PubMed    


  121. BRAR PS, Sass L, Kalarchian MA
    Advancing research on delusions: Fostering dialogue between cognitive and phenomenological researchers.
    Schizophr Res. 2021;233:62-63.
    PubMed    


    June 2021
  122. XIE Y, Xi Y, Cui LB, Li C, et al
    Altered functional connectivity of the dentate nuclei in patients with schizophrenia.
    Schizophr Res. 2021;233:16-23.
    PubMed     Abstract available


  123. BONFILS KA, Luther L, Lysaker PH
    Metacognition & social cognition differentially influence experiential & expressive negative symptoms in schizophrenia.
    Schizophr Res. 2021;233:13-15.
    PubMed    


  124. FUSAR-POLI P, Salazar de Pablo G
    Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00242.
    PubMed    


  125. BANEA OC, Bandeira Dos Santos LG, Marcu S, Stefannson SB, et al
    Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00214.
    PubMed    


  126. GAO Y, Li M, Huang AS, Anderson AW, et al
    Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia.
    Schizophr Res. 2021 Jun 29. pii: S0920-9964(21)00225.
    PubMed     Abstract available


  127. HU M, Qian X, Liu S, Koh AJ, et al
    Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks.
    Schizophr Res. 2021 Jun 28. pii: S0920-9964(21)00223.
    PubMed     Abstract available


  128. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
    Association of g-quadruplex variants with schizophrenia symptoms.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00220.
    PubMed    


  129. HU Y, Xu L, Gan R, Wu G, et al
    A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00240.
    PubMed     Abstract available


  130. CLAYSON PE, Joshi YB, Thomas ML, Tarasenko M, et al
    The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.
    Schizophr Res. 2021 Jun 26. pii: S0920-9964(21)00234.
    PubMed     Abstract available


  131. RUBIO JM, Lencz T, Barber A, Moyett A, et al
    Striatal functional connectivity in psychosis relapse: A hypothesis generating study.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00222.
    PubMed     Abstract available


  132. BARLATI S, Morena D, Nibbio G, Cacciani P, et al
    Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00219.
    PubMed     Abstract available


  133. KRONICK J, Sabesan P, Burhan AM, Palaniyappan L, et al
    Assessment of treatment resistance criteria in non-invasive brain stimulation studies of schizophrenia.
    Schizophr Res. 2021 Jun 25. pii: S0920-9964(21)00221.
    PubMed     Abstract available


  134. YESILKAYA UH, Sen M, Karamustafalioglu N
    New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus.
    Schizophr Res. 2021 Jun 16. pii: S0920-9964(21)00213.
    PubMed    


  135. METZAK PD, Farris MS, Placsko T, Braun A, et al
    Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.
    Schizophr Res. 2021;233:3-12.
    PubMed     Abstract available


  136. CORTES-BRIONES JA, Tapia-Rivas NI, D'Souza DC, Estevez PA, et al
    Going deep into schizophrenia with artificial intelligence.
    Schizophr Res. 2021 Jun 5. pii: S0920-9964(21)00179.
    PubMed     Abstract available


  137. BOMMERSBACH TJ, Rhee TG, Stefanovics EA, Rosenheck RA, et al
    Comparison of Black and white individuals who report diagnoses of schizophrenia in a national sample of US adults: Discrimination and service use.
    Schizophr Res. 2021 Jun 1. pii: S0920-9964(21)00178.
    PubMed     Abstract available


    May 2021
  138. LISOWAY AJ, Chen CC, Zai CC, Tiwari AK, et al
    Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment.
    Schizophr Res. 2021;232:112-124.
    PubMed     Abstract available


  139. ZHANG YJ, Pu CC, Wang YM, Zhang RT, et al
    Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia.
    Schizophr Res. 2021;232:77-84.
    PubMed     Abstract available


  140. SENGUTTA M, Karow A, Moritz S
    Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses.
    Schizophr Res. 2021;232:107-108.
    PubMed    


  141. FORTEA A, Batalla A, Radua J, van Eijndhoven P, et al
    Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis.
    Schizophr Res. 2021;232:98-106.
    PubMed     Abstract available


  142. WANG D, Zhuo K, Sun Y, Xiang Q, et al
    Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naive first-episode psychosis patients: A pilot longitudinal study.
    Schizophr Res. 2021;232:95-97.
    PubMed    


  143. HEGELSTAD WTV, Berg AO, Bjornestad J, Gismervik K, et al
    Childhood interpersonal trauma and premorbid social adjustment as predictors of symptom remission in first episode psychosis.
    Schizophr Res. 2021;232:87-94.
    PubMed     Abstract available


  144. WELLESLEY WESLEY E, Patel I, Kadra-Scalzo G, Pritchard M, et al
    Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register.
    Schizophr Res. 2021;232:68-76.
    PubMed     Abstract available


  145. MOXAM AB, McClellan EJ, Cagande C, Calkins ME, et al
    Few primary care pediatricians screen for psychosis but many are willing.
    Schizophr Res. 2021;232:65-67.
    PubMed    


  146. CHESLACK-POSTAVA K, Brown AS
    Prenatal infection and schizophrenia: A decade of further progress.
    Schizophr Res. 2021 May 17. pii: S0920-9964(21)00174.
    PubMed     Abstract available


  147. DEL RE EC
    The 2020 World Congress of Psychiatric Genetics: Schizophrenia highlights with an eye on sex differences.
    Schizophr Res. 2021;232:63-64.
    PubMed    


  148. BARTOLI F, Cioni RM, Callovini T, Cavaleri D, et al
    The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
    Schizophr Res. 2021;232:61-62.
    PubMed    


  149. TARGUM SD, Pendergrass JC, Murphy C
    Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.
    Schizophr Res. 2021;232:54-60.
    PubMed     Abstract available


  150. KAHN RS, Silverman BL, DiPetrillo L, Graham C, et al
    A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
    Schizophr Res. 2021;232:45-53.
    PubMed     Abstract available


  151. TIIHONEN J, Koskuvi M, Lahteenvuo M, Trontti K, et al
    Molecular signaling pathways underlying schizophrenia.
    Schizophr Res. 2021;232:33-41.
    PubMed     Abstract available


  152. SEVERANCE EG, Yolken RH
    Binning bugs and beyond: The state of the schizophrenia microbiome.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00162.
    PubMed    


  153. VANES LD, Murray RM, Nosarti C
    Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis.
    Schizophr Res. 2021 May 15. pii: S0920-9964(21)00152.
    PubMed     Abstract available


  154. SARRE A, Abdel-Ahad P, Meilland A, Renard U, et al
    Verbal hallucinations in deaf schizophrenia patients.
    Schizophr Res. 2021;232:31-32.
    PubMed    


  155. MAYORAL-VAN SON J, Juncal-Ruiz M, Ortiz-Garcia de la Foz V, Vazquez-Bourgon J, et al
    Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort.
    Schizophr Res. 2021;232:28-30.
    PubMed    


  156. WRIGHT AC, Browne J, Skiest H, Bhiku K, et al
    The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2021;232:11-27.
    PubMed     Abstract available


  157. GEBICKE-HAERTER PJ, Leonardi-Essmann F, Haerter JO, Rossner MJ, et al
    Differential gene regulation in the anterior cingulate cortex and superior temporal cortex in schizophrenia: A molecular network approach.
    Schizophr Res. 2021;232:1-10.
    PubMed     Abstract available


  158. NASKAR C
    Understanding the effect of various factors on clozapine serum levels in Indian population.
    Schizophr Res. 2021;231:178.
    PubMed    


  159. OREPIC P, Rognini G, Kannape OA, Faivre N, et al
    Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners.
    Schizophr Res. 2021;231:170-177.
    PubMed     Abstract available


  160. MISAWA F, Okumura Y, Takeuchi Y, Fujii Y, et al
    Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
    Schizophr Res. 2021;231:42-46.
    PubMed     Abstract available


    April 2021
  161. KIDD SA, Mutschler C, Lichtenstein S, Yan S, et al
    Randomized trial of a brief peer support intervention for individuals with schizophrenia transitioning from hospital to community.
    Schizophr Res. 2021;231:214-220.
    PubMed     Abstract available


  162. RUNGE K, Fiebich BL, Kuzior H, Saliba SW, et al
    An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders.
    Schizophr Res. 2021;231:205-213.
    PubMed     Abstract available


  163. TEEUW J, Ori APS, Brouwer RM, de Zwarte SMC, et al
    Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia.
    Schizophr Res. 2021;231:189-197.
    PubMed     Abstract available


  164. WANG C, Oughourlian T, Tishler TA, Anwar F, et al
    Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia.
    Schizophr Res. 2021;231:179-188.
    PubMed     Abstract available


  165. BROWNE J, Wright AC, Berry K, Mueser KT, et al
    The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis.
    Schizophr Res. 2021;231:154-163.
    PubMed     Abstract available


  166. MEKORI-DOMACHEVSKY E, Taler M, Weinberger R, Guri Y, et al
    Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
    Schizophr Res. 2021;231:164-169.
    PubMed     Abstract available


  167. PINHO S, Rocha V, Vieira-Coelho MA
    Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review.
    Schizophr Res. 2021;231:145-153.
    PubMed     Abstract available


  168. DICKERSON F, Origoni A, Katsafanas E, Squire A, et al
    Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia.
    Schizophr Res. 2021;231:142-144.
    PubMed    


  169. HOGERZEIL SJ, Hoek HW, van Hemert AM
    The impact of study design on schizophrenia incidence estimates: A systematic review of Northern European studies 2008-2019.
    Schizophr Res. 2021;231:134-141.
    PubMed     Abstract available


  170. AJNAKINA O, Stubbs B, Francis E, Gaughran F, et al
    Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies.
    Schizophr Res. 2021;231:122-133.
    PubMed     Abstract available


  171. FRAGUAS D, Diaz-Caneja CM, Pina-Camacho L, Winter van Rossum I, et al
    The role of depression in the prediction of a "late" remission in first-episode psychosis: An analysis of the OPTiMiSE study.
    Schizophr Res. 2021;231:100-107.
    PubMed     Abstract available


  172. TAO B, Xiao Y, Yang B, Zeng J, et al
    Morphological alterations of the corpus callosum in antipsychotic-naive first-episode schizophrenia before and 1-year after treatment.
    Schizophr Res. 2021;231:115-121.
    PubMed     Abstract available


  173. FREEDMAN R, Hunter SK, Law AJ, Clark AM, et al
    Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum.
    Schizophr Res. 2021 Apr 7. pii: S0920-9964(21)00128.
    PubMed     Abstract available


  174. GIBBONS RD, Chattopadhyay I, Meltzer H, Kane JM, et al
    Development of a computerized adaptive diagnostic screening tool for psychosis.
    Schizophr Res. 2021 Apr 6. pii: S0920-9964(21)00140.
    PubMed     Abstract available


  175. SOUSA AE, Ryan JD, Lepage M
    A feasibility pilot study on using unitization to circumvent relational memory impairments in schizophrenia.
    Schizophr Res. 2021;231:98-99.
    PubMed    


  176. RAO NP, Ramachandran P, Jacob A, Joseph A, et al
    Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial.
    Schizophr Res. 2021;231:90-97.
    PubMed     Abstract available


  177. MAITRA R, Pollak TA, Pritchard M, Shergill S, et al
    Stem cell transplant in psychotic disorders: Immunological cause or cure?
    Schizophr Res. 2021;230:50-52.
    PubMed    


  178. WILLIAMS MJ
    The only difference between a jail and a psychiatric hospital is a pillow.
    Schizophr Res. 2021;230:100.
    PubMed     Abstract available


    March 2021
  179. PRUESSNER M, King S, Veru F, Schalinski I, et al
    Impact of childhood trauma on positive and negative symptom remission in first episode psychosis.
    Schizophr Res. 2021;231:82-89.
    PubMed     Abstract available


  180. KOSHIYAMA D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, et al
    Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia.
    Schizophr Res. 2021;231:73-81.
    PubMed     Abstract available


  181. ADELINO MPM, Nunes MV, Nunes MFQ, Costa ER Jr, et al
    Treatment-resistant schizophrenia - A RCT on the effectiveness of repeated-dose sodium nitroprusside.
    Schizophr Res. 2021;231:70-72.
    PubMed     Abstract available


  182. YANG J, Kang C, Wu C, Lin Y, et al
    Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia.
    Schizophr Res. 2021;231:67-69.
    PubMed     Abstract available


  183. SAPERSTEIN AM, Choi CJ, Jahshan C, Lynch DA, et al
    Predicting response to cognitive training for schizophrenia using results from two studies with different outcomes.
    Schizophr Res. 2021;231:61-66.
    PubMed     Abstract available


  184. WOLF RC, Kubera KM, Waddington JL, Schmitgen MM, et al
    A neurodevelopmental signature of parkinsonism in schizophrenia.
    Schizophr Res. 2021;231:54-60.
    PubMed     Abstract available


  185. ZITO MF, Subotnik KL, Ventura J, Kern RS, et al
    Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia.
    Schizophr Res. 2021;231:51-53.
    PubMed    


  186. SUHAS S
    COVID 19 vaccination of persons with schizophrenia in India - Need for imperative action!
    Schizophr Res. 2021;231:49-50.
    PubMed    


  187. HUANG TY, Deng WF, Li XP, Chen HQ, et al
    Higher prevalence of coronary artery calcification in schizophrenia patients.
    Schizophr Res. 2021;231:47-48.
    PubMed    


  188. HAINING K, Brunner G, Gajwani R, Gross J, et al
    The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach.
    Schizophr Res. 2021;231:24-31.
    PubMed     Abstract available


  189. SCHEFFLER F, Du Plessis S, Asmal L, Kilian S, et al
    Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls.
    Schizophr Res. 2021;231:13-21.
    PubMed     Abstract available


  190. DAMIANI S, Scalabrini A, Ku HL, Lane TJ, et al
    From local to global and back: An exploratory study on cross-scale desynchronization in schizophrenia and its relation to thought disorders.
    Schizophr Res. 2021;231:10-12.
    PubMed    


  191. O'DONOGHUE B, Nelson B, Francey S, McGorry P, et al
    Response to 'Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis'.
    Schizophr Res. 2021;231:1-2.
    PubMed    


  192. NASIB LG, Gangadin SS, Rossum IW, Boudewijns ZSRM, et al
    The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial.
    Schizophr Res. 2021;230:79-86.
    PubMed     Abstract available


  193. PURUSHOTHAMAN D, Jacob AA, Kumar V, Varambally S, et al
    The dilemma of self vs others' interest: Altruistic behaviour in schizophrenia and the role of vasopressin.
    Schizophr Res. 2021;230:77-78.
    PubMed    


  194. PERRY BI, Zammit S, Jones PB, Khandaker GM, et al
    Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort.
    Schizophr Res. 2021;230:69-76.
    PubMed     Abstract available


  195. PAWELCZYK T, Grancow-Grabka M, Zurner N, Pawelczyk A, et al
    Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Schizophr Res. 2021;230:61-68.
    PubMed     Abstract available


  196. WANG DD, Hu XW, Jiang J, Sun LY, et al
    Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Schizophr Res. 2021;230:53-60.
    PubMed     Abstract available


  197. YAN W, Zhao M, Fu Z, Pearlson GD, et al
    Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: A deep classification and clustering framework using fMRI time series.
    Schizophr Res. 2021 Mar 3. pii: S0920-9964(21)00077.
    PubMed     Abstract available


  198. WANG J, Kochunov P, Sampath H, Hatch KS, et al
    White matter brain aging in relationship to schizophrenia and its cognitive deficit.
    Schizophr Res. 2021;230:9-16.
    PubMed     Abstract available


  199. MOJTABAI R
    Estimating the prevalence of schizophrenia in the United States using the multiplier method.
    Schizophr Res. 2021;230:48-49.
    PubMed    


  200. TSANG A, Bucci S, Branitsky A, Kaptan S, et al
    The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review.
    Schizophr Res. 2021;230:38-47.
    PubMed     Abstract available


  201. JACOB MS, Roach BJ, Hamilton HK, Carrion RE, et al
    Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.
    Schizophr Res. 2021;230:26-37.
    PubMed     Abstract available


  202. CHUNG AK, Chan WM, Law JK, Tse CY, et al
    Ketamine abusers with SLC6A3 rs393795 genotype showed a preliminary association with psychosis and schizophrenia: A pilot case-control study.
    Schizophr Res. 2021;230:24-25.
    PubMed    


  203. DURAND D, Strassnig MT, Moore RC, Depp CA, et al
    Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias.
    Schizophr Res. 2021;230:17-23.
    PubMed     Abstract available


  204. ENACHE D, Nikkheslat N, Fathalla D, Morgan BP, et al
    Peripheral immune markers and antipsychotic non-response in psychosis.
    Schizophr Res. 2021;230:1-8.
    PubMed     Abstract available


  205. YAEGASHI H, Misawa F, Noda H, Fujii Y, et al
    Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trials.
    Schizophr Res. 2021;229:94-101.
    PubMed     Abstract available


    February 2021
  206. SEVERANCE EG, Leister F, Lea A, Yang S, et al
    Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia.
    Schizophr Res. 2021 Feb 23. pii: S0920-9964(21)00071.
    PubMed     Abstract available


  207. SHAD MU
    Is high-dose maintenance therapy effective in treatment-refractory psychosis? A case series.
    Schizophr Res. 2021;229:38-42.
    PubMed    


  208. JOHNSON KA, Guyer M, Ongur D, Friedman-Yakoobian M, et al
    Early intervention in psychosis: Building a strategic roadmap for Massachusetts.
    Schizophr Res. 2021;229:43-45.
    PubMed    


  209. NOYAN H, Erdag E, Tuzun E, Yaylim I, et al
    Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1beta levels in patients with schizophrenia spectrum disorder and their siblings.
    Schizophr Res. 2021;229:27-37.
    PubMed     Abstract available


  210. SUHAS S, Kumar V, Venkatasubramanian G
    Therapeutic drug monitoring of clozapine in Indian patients with schizophrenia - Authors response.
    Schizophr Res. 2021;229:25-26.
    PubMed    


  211. MEHTA UM, Keshavan MS
    Hindsight 2020: Emerging research trends in schizophrenia.
    Schizophr Res. 2021;229:22-24.
    PubMed    


  212. PARIS G, Bighelli I, Deste G, Siafis S, et al
    Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis.
    Schizophr Res. 2021;229:3-11.
    PubMed     Abstract available


  213. HANLON FM, Dodd AB, Ling JM, Shaff NA, et al
    The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum.
    Schizophr Res. 2021;229:12-21.
    PubMed     Abstract available


  214. MC GLANAGHY E, Turner D, Davis GA, Sharpe H, et al
    A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms.
    Schizophr Res. 2021;228:447-459.
    PubMed     Abstract available


  215. KULKARNI G, Mehta UM, Das S, Arunachal G, et al
    Novel CTSF Indel in a patient with Kufs disease and resistant schizophrenia: A case report.
    Schizophr Res. 2021;228:435-437.
    PubMed    


  216. GAIGL G, Taumer E, Merz K, Zoscher S, et al
    Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.
    Schizophr Res. 2021;228:425-434.
    PubMed     Abstract available


  217. OH J, Nam H, Park S, Chae JH, et al
    Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study.
    Schizophr Res. 2021;228:417-424.
    PubMed     Abstract available


  218. PUNTIS S, Oliver D, Fusar-Poli P
    Third external replication of an individualised transdiagnostic prediction model for the automatic detection of individuals at risk of psychosis using electronic health records.
    Schizophr Res. 2021;228:403-409.
    PubMed     Abstract available


  219. DAR S, Liebenthal E, Pan H, Smith T, et al
    Abnormal semantic processing of threat words associated with excitement and hostility symptoms in schizophrenia.
    Schizophr Res. 2021;228:394-402.
    PubMed     Abstract available


  220. HIGGINS A, Lewandowski KE, Liukasemsarn S, Hall MH, et al
    Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.
    Schizophr Res. 2021;228:385-393.
    PubMed     Abstract available


  221. HERNIMAN SE, Cotton SM, Allott KA, Phillips LJ, et al
    The psychometric validity of the Montgomery-Asberg Depression Rating Scale (MADRS) in recent onset schizophrenia spectrum disorders.
    Schizophr Res. 2021;228:373-381.
    PubMed     Abstract available


  222. DUFVA YE, Westman H, Khilbom U, Sullivan PF, et al
    Swedish large-scale schizophrenia study: Why do patients and healthy controls participate?
    Schizophr Res. 2021;228:360-366.
    PubMed     Abstract available


  223. DIAZ-CUTRARO L, Garcia-Mieres H, Lopez-Carrilero R, Ferrer M, et al
    Jumping to conclusions is differently associated with specific subtypes of delusional experiences: An exploratory study in first-episode psychosis.
    Schizophr Res. 2021;228:357-359.
    PubMed    


  224. MCGORRY PD, Mei C, Hartmann J, Yung AR, et al
    Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis.
    Schizophr Res. 2021;228:344-356.
    PubMed     Abstract available


  225. BERRY C, Newcombe H, Strauss C, Rammou A, et al
    Validation of the Hamilton Program for Schizophrenia Voices Questionnaire: Associations with emotional distress and wellbeing, and invariance across diagnosis and sex.
    Schizophr Res. 2021;228:336-343.
    PubMed     Abstract available


  226. VER LOREN VAN THEMAAT AH, Hemager N, Korsgaard Johnsen L, Klee Burton B, et al
    Development of visual attention from age 7 to age 12 in children with familial high risk for schizophrenia or bipolar disorder.
    Schizophr Res. 2021;228:327-335.
    PubMed     Abstract available


  227. KEEFE RSE
    Where do we cut the bell-shaped curve of CIAS?
    Schizophr Res. 2021;228:633-634.
    PubMed    


  228. KOLBAEK P, Dines D, Hansen J, Opler M, et al
    Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6).
    Schizophr Res. 2021;228:438-446.
    PubMed     Abstract available


  229. LAHTEENVUO M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, et al
    Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.
    Schizophr Res. 2021;228:367-372.
    PubMed     Abstract available


  230. DAS D, Peng X, Lam AN, Bader JS, et al
    Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis.
    Schizophr Res. 2021;228:324-326.
    PubMed     Abstract available


  231. SUMNER PJ, Rossell SL, Tan EJ
    On the assessment of subjective formal thought disorder.
    Schizophr Res. 2021;228:58-59.
    PubMed    


  232. SUHAS S, Nagpal M, Rao NP, Kumar V, et al
    Echo of reading - The forgotten psychopathology: A case report.
    Schizophr Res. 2021;228:602-603.
    PubMed    


  233. RABINOWITZ J, Opler M, Rabinowitz AA, Negash S, et al
    Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP).
    Schizophr Res. 2021;228:529-533.
    PubMed     Abstract available


    January 2021
  234. MOYA LACASA C, Rayner T, Hagen MM, Yang W, et al
    Anti-cyomegalovirus antibodies in schizophrenia and related disorders: A systematic review and meta-analysis.
    Schizophr Res. 2021;228:322-323.
    PubMed    


  235. BOLBECKER AR, Apthorp D, Bartolomeo LA, O'Donnell BF, et al
    Postural sway in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2021;228:319-321.
    PubMed    


  236. LAVEBRATT C, Stiernborg M, Kumar P, Yacaman-Mendez D, et al
    Physical exercise is associated with a reduction in inflammatory biomarkers in first-episode psychosis: A pilot study of CRP, SAA, sICAM-1 and sVCAM-1.
    Schizophr Res. 2021;228:316-318.
    PubMed    


  237. KALINKOVICH A, Pouyrovsky M, Nasyrova R, Livshits G, et al
    Biased activation of inflammation pro-resolving receptors as an evolving supportive strategy in schizophrenia treatment.
    Schizophr Res. 2021;228:295-297.
    PubMed    


  238. MEHTA UM, Naik SS, Thirthalli J
    Global visuospatial processing - a screening tool to predict cognition in schizophrenia.
    Schizophr Res. 2021;228:311-313.
    PubMed    


  239. BORNHEIMER LA, Wojtalik JA, Li J, Cobia D, et al
    Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.
    Schizophr Res. 2021;228:298-304.
    PubMed     Abstract available


  240. CHAN SKW, Liu T, Wong AOY, Wong GHY, et al
    Self-referential gaze perception of patients with schizophrenia and its relationship with symptomatology and cognitive functions.
    Schizophr Res. 2021;228:288-294.
    PubMed     Abstract available


  241. KOSHIYAMA D, Miyakoshi M, Thomas ML, Joshi YB, et al
    Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
    Schizophr Res. 2021;228:280-287.
    PubMed     Abstract available


  242. HARE SM, Adhikari BM, Du X, Garcia L, et al
    Local versus long-range connectivity patterns of auditory disturbance in schizophrenia.
    Schizophr Res. 2021;228:262-270.
    PubMed     Abstract available


  243. GRIFFITHS SL, Wood SJ, Fowler D, Freemantle N, et al
    Improved social functioning following social recovery therapy in first episode psychosis: Do social cognition and neurocognition change following therapy, and do they predict treatment response?
    Schizophr Res. 2021;228:249-255.
    PubMed     Abstract available


  244. ZENG J, Zhang W, Xiao Y, Fu G, et al
    Pretreatment abnormalities in white matter integrity predict one-year clinical outcome in first episode schizophrenia.
    Schizophr Res. 2021;228:241-248.
    PubMed     Abstract available


  245. TIRUPATI S
    The risk for Torsades de Pointes and polypharmacy in schizophrenia.
    Schizophr Res. 2021;228:239-240.
    PubMed    


  246. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Iliadou V, et al
    Could early diagnosis and rehabilitation of Auditory Processing Disorder in schizophrenia have a positive effect on cognition?
    Schizophr Res. 2021;228:237-238.
    PubMed    


  247. BRUINS J, Pijnenborg GHM, Wunderink L, Visser E, et al
    The association of cannabis use with quality of life and psychosocial functioning in psychosis.
    Schizophr Res. 2021;228:229-234.
    PubMed     Abstract available


  248. CAMPANA M, Falkai P, Siskind D, Hasan A, et al
    Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis.
    Schizophr Res. 2021;228:218-226.
    PubMed     Abstract available


  249. DICKERSON F, Katsafanas E, Origoni A, Squire A, et al
    Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.
    Schizophr Res. 2021;228:193-197.
    PubMed     Abstract available


  250. BIGSETH TT, Fredriksen M, Egeland J, Andersen E, et al
    Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study.
    Schizophr Res. 2021;228:190-192.
    PubMed    


  251. CORRELL CU, Vanover KE, Davis RE, Chen R, et al
    Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia.
    Schizophr Res. 2021;228:198-205.
    PubMed     Abstract available


  252. ADDINGTON J, Santesteban-Echarri O, Braun A, Lecomte T, et al
    Assessing social functioning in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;228:188-189.
    PubMed    


  253. SZESZKO PR, McNamara RK, Gallego JA, Malhotra AK, et al
    Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.
    Schizophr Res. 2021;228:180-187.
    PubMed     Abstract available


  254. ALLE MC, Berna F, Danion JM, Berntsen D, et al
    Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories.
    Schizophr Res. 2021;228:89-96.
    PubMed     Abstract available


  255. POPE LG, Manseau MW, Kelley ME, Compton MT, et al
    Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization.
    Schizophr Res. 2021;228:83-88.
    PubMed     Abstract available


  256. SCHOONOVER KE, Farmer CB, Morgan CJ, Sinha V, et al
    Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.
    Schizophr Res. 2021;228:60-73.
    PubMed     Abstract available


  257. MUKKU SSR, Nadella RK, Sivakumar PT, Sinha P, et al
    Is late onset schizophrenia a forerunner of Frontotemporal dementia? - A case series.
    Schizophr Res. 2021;228:56-57.
    PubMed    


  258. PENNEY D, El-Baalbaki G, Lepage M
    Prevalence and severity of posttraumatic stress symptoms in psychosis: Associations with affective and patient-centered variables in those referred for psychological services.
    Schizophr Res. 2021;228:53-55.
    PubMed    


  259. ABPLANALP SJ, Gold A, Gonzalez R, Doshi S, et al
    Feasibility of using smartphones to capture speech during social interactions in schizophrenia.
    Schizophr Res. 2021;228:51-52.
    PubMed    


  260. LINCOLN SH, Johnson T, Winters A, Laquidara J, et al
    Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research.
    Schizophr Res. 2021;228:43-50.
    PubMed     Abstract available


  261. SPARK J, Gaweda L, Allott K, Hartmann JA, et al
    Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition.
    Schizophr Res. 2021;228:19-28.
    PubMed     Abstract available


  262. VILA-BADIA R, Butjosa A, Del Cacho N, Serra-Arumi C, et al
    Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psychosis? A systematic review.
    Schizophr Res. 2021;228:159-179.
    PubMed     Abstract available


  263. BOGE K, Hahne I, Bergmann N, Wingenfeld K, et al
    Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
    Schizophr Res. 2021;228:134-144.
    PubMed     Abstract available


  264. SCHOONOVER KE, Roberts RC
    Markers of copper transport in the cingulum bundle in schizophrenia.
    Schizophr Res. 2021;228:124-133.
    PubMed     Abstract available


  265. HEDBERG M, Imbeault S, Erhardt S, Schwieler L, et al
    Disrupted sensorimotor gating in first-episode psychosis patients is not affected by short-term antipsychotic treatment.
    Schizophr Res. 2021;228:118-123.
    PubMed     Abstract available


  266. SENDI MSE, Pearlson GD, Mathalon DH, Ford JM, et al
    Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia.
    Schizophr Res. 2021;228:103-111.
    PubMed     Abstract available


  267. ZHANG Y, Geyfman A, Coffman B, Gill K, et al
    Distinct alterations in resting-state electroencephalogram during eyes closed and eyes open and between morning and evening are present in first-episode psychosis patients.
    Schizophr Res. 2021;228:36-42.
    PubMed     Abstract available


  268. SMESNY S, Berberich D, Gussew A, Schonfeld N, et al
    Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up (1)H/(31)P-MR-spectroscopy study.
    Schizophr Res. 2021;228:7-18.
    PubMed     Abstract available


  269. SECCOMANDI B, Agbedjro D, Bell M, Keefe RSE, et al
    Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia.
    Schizophr Res. 2021;228:29-35.
    PubMed     Abstract available


  270. KIMURA M, Oda Y, Oishi K, Yoshino K, et al
    Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Schizophr Res. 2021;228:1-6.
    PubMed     Abstract available


  271. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;227:63-71.
    PubMed     Abstract available


  272. MALHI GS, Bell E, Hamilton A, Morris G, et al
    Early intervention for risk syndromes: What are the real risks?
    Schizophr Res. 2021;227:4-9.
    PubMed    


    December 2020
  273. ELLERSGAARD D, Gregersen M, Spang KS, Christiani C, et al
    Psychotic experiences in seven-year-old children with familial high risk of schizophrenia or bipolar disorder in: The Danish High Risk and Resilience Study - VIA 7; A population-based cohort study.
    Schizophr Res. 2020 Dec 9. pii: S0920-9964(20)30589.
    PubMed     Abstract available


  274. BOUET V, Percelay S, Leroux E, Diarra B, et al
    A new 3-hit mouse model of schizophrenia built on genetic, early and late factors.
    Schizophr Res. 2020 Dec 7. pii: S0920-9964(20)30583.
    PubMed     Abstract available


  275. MITTAL VA, Addington JM
    Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis.
    Schizophr Res. 2020 Dec 4. pii: S0920-9964(20)30554.
    PubMed    


  276. LI X, Guo X, Fan X, Feng T, et al
    Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30529.
    PubMed     Abstract available


  277. WUNDERINK L, van Bebber J, Sytema S, Boonstra N, et al
    Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Schizophr Res. 2020 Dec 2. pii: S0920-9964(20)30590.
    PubMed     Abstract available


  278. YEE CI, Vargas T, Mittal VA, Haase CM, et al
    Adaptability and cohesion in youth at clinical high-risk for psychosis: A multi-informant approach.
    Schizophr Res. 2020 Dec 1. pii: S0920-9964(20)30579.
    PubMed     Abstract available


    November 2020
  279. JABAR LSA, Sorensen HJ, Nordentoft M, Hjorthoj C, et al
    Associations between duration of untreated psychosis and domains of positive and negative symptoms persist after 10 years of follow-up: A secondary analysis from the OPUS trial.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30567.
    PubMed     Abstract available


  280. KONSZTOWICZ S, Gelencser CR, Otis C, Schmitz N, et al
    Self-concept and Engagement in LiFe (SELF): A waitlist-controlled pilot study of a novel psychological intervention to target illness engulfment in enduring schizophrenia and related psychoses.
    Schizophr Res. 2020 Nov 30. pii: S0920-9964(20)30568.
    PubMed     Abstract available


  281. PIERRE JM
    Diagnostic uncertainty, antipsychotic dosing, and optimal psychosocial interventions: Unanswered questions in first-episode psychosis.
    Schizophr Res. 2020 Nov 27. pii: S0920-9964(20)30582.
    PubMed    


  282. BERENDSEN S, Kapitein P, Schirmbeck F, van Tricht MJ, et al
    Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30429.
    PubMed    


  283. DIJKSTRA AA, Gami-Patel P, Rozemuller AJM, Bugiani M, et al
    Reduction of GABA subunit theta-containing cortical neurons in schizophrenia.
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30577.
    PubMed    


  284. CADENHEAD KS, Stone WS
    Commentary: Special issue on "Biomarkers in the attenuated psychosis syndrome".
    Schizophr Res. 2020 Nov 23. pii: S0920-9964(20)30575.
    PubMed    


  285. ZHANG H, Wang D, Chen J, Wang Y, et al
    Rare variations in the SHANK3 gene confers susceptibility to schizophrenia in Uygur Chinese population.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30576.
    PubMed    


  286. SCHULTZE-LUTTER F, Schimmelmann BG, Michel C
    Clinical high-risk of and conversion to psychosis in the community: A 3-year follow-up of a cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30572.
    PubMed    


  287. LAWRENCE RE, Appelbaum PS, Lieberman JA
    A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30562.
    PubMed     Abstract available


  288. SEMENNOV IV, Zhilyaeva TV, Kasyanov ED, Mishanov GA, et al
    Association of tetrahydrobiopterin deficiency with disturbances in one-carbon metabolism in patients with schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30563.
    PubMed    


  289. FUSAR-POLI P, Oliver D, Spada G, Estrade A, et al
    The case for improved transdiagnostic detection of first-episode psychosis: Electronic health record cohort study.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30571.
    PubMed     Abstract available


  290. PARLAR ME, Heinrichs RW
    Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30560.
    PubMed     Abstract available


  291. ZOPF R, Boulton K, Langdon R, Rich AN, et al
    Perception of visual-tactile asynchrony, bodily perceptual aberrations, and bodily illusions in schizophrenia.
    Schizophr Res. 2020 Nov 21. pii: S0920-9964(20)30578.
    PubMed     Abstract available


  292. NASLUND JA, Hswen Y
    Person-based machine learning: Accounting for patient experience to explain the nature of schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30569.
    PubMed    


  293. BITSCH F, Berger P, Nagels A, Falkenberg I, et al
    Characterizing the theory of mind network in schizophrenia reveals a sparser network structure.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30566.
    PubMed     Abstract available


  294. FUJIKAWA R, Yamada J, Jinno S
    Subclass imbalance of parvalbumin-expressing GABAergic neurons in the hippocampus of a mouse ketamine model for schizophrenia, with reference to perineuronal nets.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30555.
    PubMed     Abstract available


  295. TSO IF, Angstadt M, Rutherford S, Peltier S, et al
    Dynamic causal modeling of eye gaze processing in schizophrenia.
    Schizophr Res. 2020 Nov 20. pii: S0920-9964(20)30551.
    PubMed     Abstract available


  296. FERNANDEZ-LINSENBARTH I, Planchuelo-Gomez A, Diez A, Arjona-Valladares A, et al
    Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30552.
    PubMed     Abstract available


  297. REFISCH A, Chung HY, Komatsuzaki S, Schumann A, et al
    A common variation in HCN1 is associated with heart rate variability in schizophrenia.
    Schizophr Res. 2020 Nov 18. pii: S0920-9964(20)30556.
    PubMed     Abstract available


  298. ZHANG X, Liu W, Guo F, Li C, et al
    Disrupted structural covariance network in first episode schizophrenia patients: Evidence from a large sample MRI-based morphometric study.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30501.
    PubMed     Abstract available


  299. GAEBEL W, Stricker J, Hasan A, Falkai P, et al
    The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.
    Schizophr Res. 2020 Nov 14. pii: S0920-9964(20)30530.
    PubMed    


  300. HAARSMA J, Kok P, Browning M
    The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30496.
    PubMed     Abstract available


  301. SANDSTEN KE, Parnas J
    Altered self-recognition in schizophrenia - A reply to critics.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30494.
    PubMed    


  302. LAGAN S, Camacho E, Torous J
    Is there a clinically relevant, publicly accessible app for that? Exploring the clinical relevance and availability of mobile apps for schizophrenia and psychosis.
    Schizophr Res. 2020 Nov 13. pii: S0920-9964(20)30525.
    PubMed    


  303. INTSON K, Geissah S, McCullumsmith RE, Ramsey AJ, et al
    A role for endothelial NMDA receptors in the pathophysiology of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30491.
    PubMed     Abstract available


  304. GREENWOOD TA, Swerdlow NR, Sprock J, Calkins ME, et al
    Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia.
    Schizophr Res. 2020 Nov 11. pii: S0920-9964(20)30500.
    PubMed     Abstract available


  305. MALASPINA D, Gonen O, Rhodes H, Hoffman KW, et al
    Hippocampal metabolite concentrations in schizophrenia vary in association with rare gene variants in the TRIO gene.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30498.
    PubMed    


  306. PATEL RS, Sreeram V, Vadukapuram R, Baweja R, et al
    Do cannabis use disorders increase medication non-compliance in schizophrenia?: United States Nationwide inpatient cross-sectional study.
    Schizophr Res. 2020 Nov 9. pii: S0920-9964(20)30499.
    PubMed     Abstract available


    October 2020
  307. JUTLA A, Califano A, Dishy G, Hesson H, et al
    Neurodevelopmental predictors of conversion to schizophrenia and other psychotic disorders in adolescence and young adulthood in clinical high risk individuals.
    Schizophr Res. 2020 Oct 31. pii: S0920-9964(20)30495.
    PubMed    


  308. CARRION RE, Auther AM, McLaughlin D, Addington J, et al
    Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
    Schizophr Res. 2020 Oct 30. pii: S0920-9964(20)30464.
    PubMed     Abstract available


  309. YU L, Fang X, Chen Y, Wang Y, et al
    Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2020 Oct 28. pii: S0920-9964(20)30493.
    PubMed     Abstract available


  310. NAGENDRA A, Halverson TF, Pinkham AE, Harvey PD, et al
    Neighborhood socioeconomic status and racial disparities in schizophrenia: An exploration of domains of functioning.
    Schizophr Res. 2020 Oct 24. pii: S0920-9964(20)30478.
    PubMed     Abstract available


  311. SKLAR AL, Coffman BA, Haas G, Ghuman A, et al
    Inefficient visual search strategies in the first-episode schizophrenia spectrum.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30473.
    PubMed     Abstract available


  312. PEREZ MM, Tercero BA, Penn DL, Pinkham AE, et al
    Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals.
    Schizophr Res. 2020 Oct 20. pii: S0920-9964(20)30492.
    PubMed     Abstract available


  313. RAPADO-CASTRO M, Whittle S, Pantelis C, Thompson A, et al
    Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk?
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30475.
    PubMed     Abstract available


  314. GOLDRING A, Borne S, Hefner A, Thanju A, et al
    The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30436.
    PubMed     Abstract available


  315. EGERTON A, Grace AA, Stone J, Bossong MG, et al
    Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
    Schizophr Res. 2020 Oct 15. pii: S0920-9964(20)30471.
    PubMed     Abstract available


  316. SPENCER HM, Dudley R, Freeston MH, Turkington D, et al
    What are the essential ingredients of a CBT case conceptualization for voices and delusions in schizophrenia spectrum disorders? A study of expert consensus.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30484.
    PubMed     Abstract available


  317. BHATTACHARYYA S, Schoeler T, Patel R, di Forti M, et al
    Individualized prediction of 2-year risk of relapse as indexed by psychiatric hospitalization following psychosis onset: Model development in two first episode samples.
    Schizophr Res. 2020 Oct 14. pii: S0920-9964(20)30474.
    PubMed     Abstract available


  318. FRITZE S, Thieme CE, Kubera KM, Northoff G, et al
    Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30483.
    PubMed     Abstract available


  319. WHITTON AE, Merchant JT, Lewandowski KE
    Dissociable mechanisms underpinning effort-cost decision-making across the psychosis spectrum.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30472.
    PubMed     Abstract available


  320. MISHRA R, Mathur R, Verma R
    Altered self-recognition in schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30469.
    PubMed    


  321. TERNOVOY S, Ustyuzhanin D, Morozova Y, Shariya M, et al
    Functional MRI evince the safety and efficacy of umbilical cord blood cells therapy in patients with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30486.
    PubMed    


  322. BUCHANAN A, Sint K, Stefanovics E, Rosenheck R, et al
    An 18-month longitudinal study of suicidality in patients diagnosed with schizophrenia.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30477.
    PubMed     Abstract available


  323. WORTHINGTON MA, Walker EF, Addington J, Bearden CE, et al
    Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30480.
    PubMed     Abstract available


  324. CORCORAN CM
    Commentary on "Lower speech connectedness linked to incidence of psychosis in people at clinical high risk": The promise of graph theory and network neuroscience.
    Schizophr Res. 2020 Oct 9. pii: S0920-9964(20)30482.
    PubMed    


  325. PARRISH EM, Depp CA, Moore RC, Harvey PD, et al
    Emotional determinants of life-space through GPS and ecological momentary assessment in schizophrenia: What gets people out of the house?
    Schizophr Res. 2020;224:67-73.
    PubMed     Abstract available


  326. FENG T, McEvoy JP, Miller BJ
    Longitudinal study of inflammatory markers and psychopathology in schizophrenia.
    Schizophr Res. 2020;224:58-66.
    PubMed     Abstract available


    September 2020
  327. TORII Y, Iritani S, Sekiguchi H, Habuchi C, et al
    The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30470.
    PubMed    


  328. WEZENBERG BN, Hagen JM, Sutterland AL, Schrantee A, et al
    Association between Advanced Glycation End products and brain volumes in recent onset psychosis.
    Schizophr Res. 2020 Sep 29. pii: S0920-9964(20)30468.
    PubMed    


  329. PUJOL N, Mane A, Berge D, Mezquida G, et al
    Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30430.
    PubMed     Abstract available


  330. PARK YW, Choi D, Lee J, Ahn SS, et al
    Differentiating patients with schizophrenia from healthy controls by hippocampal subfields using radiomics.
    Schizophr Res. 2020 Sep 25. pii: S0920-9964(20)30467.
    PubMed     Abstract available


  331. MORRENS M, De Picker L, Kampen JK, Coppens V, et al
    Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis.
    Schizophr Res. 2020 Sep 24. pii: S0920-9964(20)30465.
    PubMed     Abstract available


  332. MARKOVIC A, Buckley A, Driver DI, Dillard-Broadnax D, et al
    Sleep spindle activity in childhood onset schizophrenia: Diminished and associated with clinical symptoms.
    Schizophr Res. 2020 Sep 23. pii: S0920-9964(20)30450.
    PubMed     Abstract available


  333. FRIEDMAN-YAKOOBIAN MS, Parrish EM, Eack SM, Keshavan MS, et al
    Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial.
    Schizophr Res. 2020 Sep 22. pii: S0920-9964(20)30461.
    PubMed     Abstract available


  334. HUMPSTON C, Harrow M, Rosen C
    Behind the opaque curtain: A 20-year longitudinal study of dissociative and first-rank symptoms in schizophrenia-spectrum psychoses, other psychoses and non-psychotic disorders.
    Schizophr Res. 2020 Sep 19. pii: S0920-9964(20)30412.
    PubMed     Abstract available


  335. PRUETT BS, Meador-Woodruff JH
    Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Sep 18. pii: S0920-9964(20)30459.
    PubMed     Abstract available


  336. SPENCER TJ, Thompson B, Oliver D, Diederen K, et al
    Lower speech connectedness linked to incidence of psychosis in people at clinical high risk.
    Schizophr Res. 2020 Sep 17. pii: S0920-9964(20)30458.
    PubMed     Abstract available


  337. NAKAMURA R, Asami T, Yoshimi A, Kato D, et al
    Illness management and recovery program induced neuroprotective effects on language network in schizophrenia.
    Schizophr Res. 2020 Sep 16. pii: S0920-9964(20)30454.
    PubMed    


  338. PETROVIC-VAN DER DEEN FS, Cunningham R, Manuel J, Gibb S, et al
    Exploring indigenous ethnic inequities in first episode psychosis in New Zealand - A national cohort study.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30460.
    PubMed     Abstract available


  339. KINNUNEN L, Nordstrom T, Niemela M, Rasanen S, et al
    Parental somatic illnesses and their association with prodromal symptoms of psychosis among offspring.
    Schizophr Res. 2020 Sep 15. pii: S0920-9964(20)30448.
    PubMed    


  340. DANEAULT JG, Shah JL
    Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30388.
    PubMed    


  341. CALKINS ME, Woods SW, Bearden CE, Liu L, et al
    Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis.
    Schizophr Res. 2020 Sep 14. pii: S0920-9964(20)30442.
    PubMed     Abstract available


  342. GAMA MARQUES J, Bento A
    Homeless, nameless and helpless: John Doe syndrome in treatment resistant schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30455.
    PubMed    


  343. BRIEND F, Nathou C, Delcroix N, Dollfus S, et al
    A new toolbox to compare target localizations for non-invasive brain stimulation: An application of rTMS treatment for auditory hallucinations in schizophrenia.
    Schizophr Res. 2020 Sep 12. pii: S0920-9964(20)30457.
    PubMed     Abstract available


  344. HARVEY PD, Horan WP, Atkins AS, Stevens H, et al
    Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30438.
    PubMed     Abstract available


  345. SARAC C, Bilgrami ZR, Haas SS, Herrera SN, et al
    Processing speed and brain volume in individuals at clinical high-risk for psychosis with comorbid eating disorders: A brief report.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30453.
    PubMed    


  346. BURRER A, Caravaggio F, Manoliu A, Plitman E, et al
    Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30446.
    PubMed     Abstract available


  347. FAAY MDM, van Baal GCM, Arango C, Diaz-Caneja CM, et al
    Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial.
    Schizophr Res. 2020 Sep 11. pii: S0920-9964(20)30449.
    PubMed     Abstract available


  348. REMPFER MV, McDowd JM, Brown CE
    Longitudinal stability of learning potential in people with schizophrenia: A 2.5 year follow-up.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30447.
    PubMed    


  349. RAJALU BM, Jayarajan D, Muliyala KP, Sharma P, et al
    Self-reported tobacco use and urine cotinine levels in persons with schizophrenia.
    Schizophr Res. 2020 Sep 4. pii: S0920-9964(20)30452.
    PubMed    


    August 2020
  350. NEILL E, Tan EJ, Toh WL, Selvendra A, et al
    Examining which factors influence age of onset in males and females with schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30439.
    PubMed     Abstract available


  351. WUTHRICH F, Pavlidou A, Stegmayer K, Eisenhardt S, et al
    Nonverbal communication remains untouched: No beneficial effect of symptomatic improvement on poor gesture performance in schizophrenia.
    Schizophr Res. 2020 Aug 31. pii: S0920-9964(20)30441.
    PubMed     Abstract available


  352. GLENTHOJ LB, Mariegaard LS, Fagerlund B, Jepsen JRM, et al
    Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.
    Schizophr Res. 2020 Aug 29. pii: S0920-9964(20)30444.
    PubMed     Abstract available


  353. SON S, Arai M, Miyata J, Toriumi K, et al
    Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia.
    Schizophr Res. 2020 Aug 22. pii: S0920-9964(20)30435.
    PubMed     Abstract available


  354. PERRY BI, Jones HJ, Richardson TG, Zammit S, et al
    Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort.
    Schizophr Res. 2020 Aug 19. pii: S0920-9964(20)30434.
    PubMed     Abstract available


  355. VAN ASSCHE L, Emsell L, Claes L, Van de Ven L, et al
    Hippocampal volume as a vulnerability marker for late onset psychosis: Associations with memory function and childhood trauma.
    Schizophr Res. 2020 Aug 17. pii: S0920-9964(20)30432.
    PubMed    


  356. KODESH A, Goldberg Y, Rotstein A, Weinstein G, et al
    Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study.
    Schizophr Res. 2020 Aug 14. pii: S0920-9964(20)30413.
    PubMed     Abstract available


  357. DAVIDSON L
    Commentary on "Relationships between psychiatric symptoms, functioning and personal recovery in psychosis" by Best et al.
    Schizophr Res. 2020 Aug 10. pii: S0920-9964(20)30431.
    PubMed    


  358. ERSHOVA ES, Malinovskaya EM, Golimbet VE, Lezheiko TV, et al
    Copy number variations of satellite III (1q12) and ribosomal repeats in health and schizophrenia.
    Schizophr Res. 2020 Aug 6. pii: S0920-9964(20)30415.
    PubMed     Abstract available


  359. HIDESE S, Ota M, Matsuo J, Ishida I, et al
    Association between obesity and white matter microstructure impairments in patients with schizophrenia: A whole-brain magnetic resonance imaging study.
    Schizophr Res. 2020 Aug 5. pii: S0920-9964(20)30395.
    PubMed     Abstract available


  360. DAVIS BJ, Lysaker PH, Salyers MP, Minor KS, et al
    The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30403.
    PubMed     Abstract available


  361. HWANG WJ, Cho KIK, Kwak YB, Lee J, et al
    Intact thalamic microstructure in asymptomatic relatives of schizophrenia patients with high genetic loading.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30394.
    PubMed     Abstract available


  362. LANGER AI, Schmidt C, Vergara R, Mayol-Troncoso R, et al
    Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial.
    Schizophr Res. 2020 Aug 3. pii: S0920-9964(20)30398.
    PubMed    


  363. RAJKUMAR RP
    The DOSMD challenge and the COVID-19 conundrum.
    Schizophr Res. 2020;222:475-476.
    PubMed    


  364. GROVER S, Mishra E, Chakrabarti S, Mehra A, et al
    Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic.
    Schizophr Res. 2020;222:489-490.
    PubMed    


    July 2020
  365. BALZAN RP, Moritz S
    Cognitive biases and psychosis: From bench to bedside.
    Schizophr Res. 2020 Jul 30. pii: S0920-9964(20)30400.
    PubMed    


  366. RAGLAND JD, Liu XL, Williams AB, Tully LM, et al
    Retrieval practice facilitation of family psychoeducation in people with early psychosis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30402.
    PubMed     Abstract available


  367. MISIAK B, Wisniewski M, Lis M, Samochowiec J, et al
    Glucose homeostasis in unaffected first-degree relatives of schizophrenia patients: A systematic review and meta-analysis.
    Schizophr Res. 2020 Jul 29. pii: S0920-9964(20)30397.
    PubMed     Abstract available


  368. O'HARE KJM, Korhonen T, Latvala A, Kaprio J, et al
    Association of subclinical psychosis with suicidal ideation: A twin study.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30396.
    PubMed     Abstract available


  369. AVERY SN, McHugo M, Armstrong K, Blackford JU, et al
    Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia.
    Schizophr Res. 2020 Jul 28. pii: S0920-9964(20)30393.
    PubMed     Abstract available


  370. YANG Y, Ning X, Wang X, Wang J, et al
    Triglyceride/glucose index is a reliable predictor of insulin resistance in schizophrenia.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30392.
    PubMed    


  371. BANNAI D, Lutz O, Lizano P
    Neuroimaging considerations when investigating choroid plexus morphology in idiopathic psychosis.
    Schizophr Res. 2020 Jul 27. pii: S0920-9964(20)30399.
    PubMed    


  372. SYDNOR VJ, Roalf DR
    A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.
    Schizophr Res. 2020 Jul 25. pii: S0920-9964(20)30380.
    PubMed     Abstract available


  373. ALI SA, Moyett A, Argyelan M, Barber AD, et al
    The effects of lorazepam on cortico-striatal connectivity in schizophrenia.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30390.
    PubMed    


  374. PETROS N, Cullen AE, Fusar-Poli P, Mechelli A, et al
    Towards standardising the assessment of good outcome in people at clinical high risk for psychosis: A collaborative approach.
    Schizophr Res. 2020 Jul 24. pii: S0920-9964(20)30391.
    PubMed    


  375. TORII Y, Iritani S, Marui T, Sekiguchi H, et al
    Morphological alteration of myelin-oligodendrocytes in a schizophrenic patient with 22q11.2 deletion syndrome: An autopsy study.
    Schizophr Res. 2020 Jul 22. pii: S0920-9964(20)30389.
    PubMed    


  376. CUI H, Giuliano AJ, Zhang T, Xu L, et al
    Cognitive dysfunction in a psychotropic medication-naive, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Schizophr Res. 2020 Jul 18. pii: S0920-9964(20)30370.
    PubMed     Abstract available


  377. LINDENMAYER JP, Goldring A, Borne S, Khan A, et al
    Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia.
    Schizophr Res. 2020 Jul 17. pii: S0920-9964(20)30387.
    PubMed     Abstract available


  378. WANG Y, Wei Y, Edmiston EK, Womer FY, et al
    Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30298.
    PubMed     Abstract available


  379. JANSEN JE, Gleeson J, Bendall S, Rice S, et al
    Acceptance-and mindfulness-based interventions for persons with psychosis: Authors reply.
    Schizophr Res. 2020 Jul 16. pii: S0920-9964(20)30374.
    PubMed    


  380. GOTRA MY, Hill SK, Gershon ES, Tamminga CA, et al
    Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.
    Schizophr Res. 2020 Jul 13. pii: S0920-9964(20)30385.
    PubMed     Abstract available


  381. EACK SM, Keshavan MS
    Cognition, negative symptoms, and functional outcome in psychosis.
    Schizophr Res. 2020 Jul 6. pii: S0920-9964(20)30381.
    PubMed    


  382. KARPINSKI P, Samochowiec J, Sasiadek MM, Laczmanski L, et al
    Analysis of global gene expression at seven brain regions of patients with schizophrenia.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30384.
    PubMed     Abstract available


  383. HABTEWOLD TD, Liemburg EJ, Islam MA, de Zwarte SMC, et al
    Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls.
    Schizophr Res. 2020 Jul 3. pii: S0920-9964(20)30272.
    PubMed     Abstract available


  384. CHAUMETTE B, Sengupta SM, Lepage M, Malla A, et al
    A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.
    Schizophr Res. 2020 Jul 2. pii: S0920-9964(20)30371.
    PubMed     Abstract available


    June 2020
  385. BEST MW, Law H, Pyle M, Morrison AP, et al
    Relationships between psychiatric symptoms, functioning and personal recovery in psychosis.
    Schizophr Res. 2020 Jun 30. pii: S0920-9964(20)30378.
    PubMed     Abstract available


  386. MATHESON GJ, Plaven-Sigray P, Louzolo A, Borg J, et al
    Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(20)30345.
    PubMed     Abstract available


  387. CHATURVEDI R, Kraus M, Keefe RSE
    A new measure of authentic auditory emotion recognition: Application to patients with schizophrenia.
    Schizophr Res. 2020 Jun 29. pii: S0920-9964(19)30550.
    PubMed     Abstract available


  388. BECHI M, Crespi SA, Agostoni G, Prudenziati F, et al
    The role of agency in schizophrenia: A pilot study on gaze agency.
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30377.
    PubMed    


  389. WADDINGTON JL
    Early intervention services for psychosis in the metaphorical 'trenches' of contemporary care: Already known from the real trenches of WW1?
    Schizophr Res. 2020 Jun 28. pii: S0920-9964(20)30373.
    PubMed    


  390. GARCIA-MIERES H, Usall J, Feixas G, Ochoa S, et al
    Gender differences in the complexity of personal identity in psychosis.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30376.
    PubMed    


  391. PURUSHOTHAMAN D, Jacob A, Kumar V, Varambally S, et al
    "To co-operate or not?" Risky co-operative behavior in Schizophrenia and the effect of vasopressin.
    Schizophr Res. 2020 Jun 27. pii: S0920-9964(20)30365.
    PubMed     Abstract available


  392. CANAL-RIVERO M, Ruiz-Veguilla M, Labad J, Ayesa-Arriola R, et al
    Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis patients: A three-year follow-up study.
    Schizophr Res. 2020 Jun 26. pii: S0920-9964(20)30363.
    PubMed    


  393. LEON-ORTIZ P, Reyes-Madrigal F, Kochunov P, Gomez-Cruz G, et al
    White matter alterations and the conversion to psychosis: A combined diffusion tensor imaging and glutamate (1)H MRS study.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30358.
    PubMed     Abstract available


  394. LARSEN KM, Dzafic I, Darke H, Pertile H, et al
    Aberrant connectivity in auditory precision encoding in schizophrenia spectrum disorder and across the continuum of psychotic-like experiences.
    Schizophr Res. 2020 Jun 25. pii: S0920-9964(20)30341.
    PubMed     Abstract available


  395. KAFADAR E, Mittal VA, Strauss GP, Chapman HC, et al
    Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30224.
    PubMed     Abstract available


  396. LASALVIA A, Vita A, Bellomo A, Tusconi M, et al
    Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy.
    Schizophr Res. 2020 Jun 24. pii: S0920-9964(20)30157.
    PubMed     Abstract available


  397. WOOD L, Williams C, Billings J, Johnson S, et al
    A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30152.
    PubMed     Abstract available


  398. CHAVES CB, Vieira-Coelho MA
    Clinical trials with monoclonal antibodies in schizophrenia.
    Schizophr Res. 2020 Jun 22. pii: S0920-9964(20)30278.
    PubMed    


  399. OLIVER D, Spada G, Colling C, Broadbent M, et al
    Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis.
    Schizophr Res. 2020 Jun 19. pii: S0920-9964(20)30259.
    PubMed     Abstract available


  400. POLETTI M, Raballo A
    Disembodiment and schizophrenia: Looking at the motor roots of minimal self disorders in a developmental perspective.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30359.
    PubMed    


  401. FERRARELLI F
    Ketamine, NMDA hypofunction, and sleep oscillatory abnormalities in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30361.
    PubMed    


  402. SABOUR S
    Clozapine screening in people taking clozapine: Understanding diagnostic accuracy in schizophrenia.
    Schizophr Res. 2020 Jun 18. pii: S0920-9964(20)30364.
    PubMed    


  403. MAGUIRE J, Sizer H, Mifsud N, O'Donoghue B, et al
    Outcomes for migrants with a first episode of psychosis: A systematic review.
    Schizophr Res. 2020 Jun 16. pii: S0920-9964(20)30302.
    PubMed     Abstract available


  404. DONDE C, Achim AM, Brunelin J, Poulet E, et al
    A meta-analysis of craving studies in schizophrenia spectrum disorders.
    Schizophr Res. 2020 Jun 15. pii: S0920-9964(20)30300.
    PubMed     Abstract available


  405. KOCH E, Rosenthal B, Lundquist A, Chen CH, et al
    Interactome overlap between schizophrenia and cognition.
    Schizophr Res. 2020 Jun 13. pii: S0920-9964(20)30346.
    PubMed     Abstract available


  406. SONI S, Muthukrishnan SP, Sood M, Kaur S, et al
    Altered parahippocampal gyrus activation and its connectivity with resting-state network areas in schizophrenia: An EEG study.
    Schizophr Res. 2020 Jun 10. pii: S0920-9964(20)30177.
    PubMed     Abstract available


  407. HASSON-OHAYON I, Scholte-Stalenhoef AN, Schirmbeck F, de Haan L, et al
    Insight, personality, and symptoms among individuals with psychosis: Cross-sectional and longitudinal relationships.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30296.
    PubMed     Abstract available


  408. SANTESTEBAN-ECHARRI O, Haffey P, Kim G, Tang J, et al
    A mobile-based app to monitor cannabis use among youth at clinical high risk (CHR) for psychosis: Feasibility and acceptability of LooseLeaf.
    Schizophr Res. 2020 Jun 8. pii: S0920-9964(20)30285.
    PubMed    


  409. STRAUSS GP, Pelletier-Baldelli A, Visser KF, Walker EF, et al
    A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Schizophr Res. 2020 Jun 7. pii: S0920-9964(20)30226.
    PubMed     Abstract available


  410. GARCIA-MIERES H, De Jesus-Romero R, Ochoa S, Feixas G, et al
    Beyond the cognitive insight paradox: Self-reflectivity moderates the relationship between depressive symptoms and general psychological distress in psychosis.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30279.
    PubMed     Abstract available


  411. CASTELNOVO A, Aquilino D, Parabiaghi A, D'Agostino A, et al
    Could CBT sustain long-term remission without antipsychotic medication in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30340.
    PubMed    


  412. SADH K, Mehta UM, Muralidharan K, Shankar NS, et al
    Understanding the role of language in patients with psychosis and hearing impairment, experiencing auditory verbal hallucinations.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30343.
    PubMed    


  413. UZER-KREMERS L, Bralet MC, Angerville B, Jeanblanc J, et al
    Is self-compassion linked to treatment adherence in schizophrenia?
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30338.
    PubMed    


  414. SUHAS S, Kumar V, Damodharan D, Sharma P, et al
    Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study.
    Schizophr Res. 2020 Jun 6. pii: S0920-9964(20)30337.
    PubMed     Abstract available


  415. VAN DER VEN E, Scodes J, Basaraba C, Pauselli L, et al
    Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York state.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30331.
    PubMed     Abstract available


  416. BOLDRINI T, Pontillo M, Tanzilli A, Giovanardi G, et al
    An attachment perspective on the risk for psychosis: Clinical correlates and the predictive value of attachment patterns and mentalization.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30332.
    PubMed     Abstract available


  417. GROVER S, Shouan A, Chakrabarti S, Sahoo S, et al
    Effectiveness of ECT in Management of Depression in patients with schizophrenia: An Open Labelled Study.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30254.
    PubMed    


  418. ZEPPILLO T, Schulmann A, Macciardi F, Hjelm BE, et al
    Functional impairment of cortical AMPA receptors in schizophrenia.
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30147.
    PubMed     Abstract available


  419. MORITZ S, Scheunemann J, Ludtke T, Westermann S, et al
    Prolonged rather than hasty decision-making in schizophrenia using the box task. Must we rethink the jumping to conclusions account of paranoia?
    Schizophr Res. 2020 Jun 5. pii: S0920-9964(20)30336.
    PubMed     Abstract available


  420. KUBOTA M, Moriguchi S, Takahata K, Nakajima S, et al
    Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30180.
    PubMed     Abstract available


  421. BASAVARAJU R, Ithal D, Ramalingaiah AH, Thirthalli J, et al
    "Apathetic to hypomanic/manic": A case series-illustration of emergent mood symptoms during intermittent theta burst stimulation (iTBS) of cerebellar vermis in schizophrenia with predominant negative symptoms.
    Schizophr Res. 2020 Jun 3. pii: S0920-9964(20)30291.
    PubMed    


  422. DEAN B, Pavey G, Scarr E
    Higher levels of alpha7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30288.
    PubMed     Abstract available


  423. CHANG CK, Chen PH, Pan CH, Su SS, et al
    Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30265.
    PubMed     Abstract available


  424. BARTH C, Jorgensen KN, Wortinger LA, Nerland S, et al
    Trajectories of brain volume change over 13 years in chronic schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30266.
    PubMed    


  425. HERNANDEZ-GARCIA M, Martin-Gomez C, Gomez-Garcia M, Gomez-Pilar J, et al
    Abnormal self-experiences related to a hypersynchronic brain state in schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30167.
    PubMed    


  426. LUTZ O, Lizano P, Mothi SS, Zeng V, et al
    Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30087.
    PubMed     Abstract available


  427. ZAHEER J, Olfson M, Mallia E, Lam JSH, et al
    Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30232.
    PubMed     Abstract available


  428. SCHNELL T, Moritz S
    Less self-stigmatization and more empowerment in patients with schizophrenia and comorbid cannabis use disorder compared to non-comorbid schizophrenia.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30268.
    PubMed    


  429. COUSTALS N, Martelli C, Brunet-Lecomte M, Petillion A, et al
    Chronic smoking and cognition in patients with schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30182.
    PubMed     Abstract available


  430. XI C, Liu ZN, Yang J, Zhang W, et al
    Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30252.
    PubMed     Abstract available


  431. DEVYLDER JE
    Letter to the editor re: "Delay discounting abnormalities are seen in first-episode schizophrenia but not in bipolar disorder" by Wang et al.
    Schizophr Res. 2020 Jun 2. pii: S0920-9964(20)30215.
    PubMed    


  432. KELLEHER E, McNamara P, Dunne J, Fitzmaurice B, et al
    Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(19)30530.
    PubMed     Abstract available


  433. CORCORAN CM, Mittal VA, Bearden CE, E Gur R, et al
    Language as a biomarker for psychosis: A natural language processing approach.
    Schizophr Res. 2020 Jun 1. pii: S0920-9964(20)30247.
    PubMed     Abstract available


  434. IFTENI P, Dima L, Teodorescu A
    Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge.
    Schizophr Res. 2020;220:265-266.
    PubMed    


    May 2020
  435. CHWA WJ, Tishler TA, Raymond C, Tran C, et al
    Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients.
    Schizophr Res. 2020 May 31. pii: S0920-9964(20)30207.
    PubMed     Abstract available


  436. WOODWARD ML, Lin J, Gicas KM, Su W, et al
    Medial temporal lobe cortical changes in response to exercise interventions in people with early psychosis: A randomized controlled trial.
    Schizophr Res. 2020 May 30. pii: S0920-9964(20)30297.
    PubMed     Abstract available


  437. MEISEBERG J, Moritz S
    Biases in diagnostic terminology: Clinicians choose different symptom labels depending on whether the same case is framed as depression or schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30161.
    PubMed     Abstract available


  438. OH SJ, Fan X
    Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30304.
    PubMed    


  439. MARINO L, Scodes J, Richkin T, Alves-Bradford JM, et al
    Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.
    Schizophr Res. 2020 May 28. pii: S0920-9964(20)30289.
    PubMed     Abstract available


  440. LIU J, Lim MSM, Ng BT, Chong SA, et al
    Global emotion dysregulation and maladaptive cognitive emotion regulation strategies mediate the effects of severe trauma on depressive and positive symptoms in early non-affective psychosis.
    Schizophr Res. 2020 May 27. pii: S0920-9964(20)30294.
    PubMed     Abstract available


  441. ALMULLA AF, Al-Hakeim HK, Abed MS, Carvalho AF, et al
    Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30255.
    PubMed     Abstract available


  442. RADUA J, Davies C, Fusar-Poli P
    Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30262.
    PubMed     Abstract available


  443. NICHOLS J, Gannon JM, Conlogue J, Sarpal D, et al
    Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30333.
    PubMed    


  444. FERRARELLI F
    Sleep disturbances in schizophrenia and psychosis.
    Schizophr Res. 2020 May 26. pii: S0920-9964(20)30274.
    PubMed    


  445. WANG X, Lu F, Duan X, Han S, et al
    Frontal white matter abnormalities reveal the pathological basis underlying negative symptoms in antipsychotic-naive, first-episode patients with adolescent-onset schizophrenia: Evidence from multimodal brain imaging.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30293.
    PubMed     Abstract available


  446. COSTANTINI M, Salone A, Martinotti G, Fiori F, et al
    Body representations and basic symptoms in schizophrenia.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30292.
    PubMed     Abstract available


  447. MONGAN D, Sabherwal S, Susai SR, Focking M, et al
    Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies.
    Schizophr Res. 2020 May 24. pii: S0920-9964(20)30290.
    PubMed     Abstract available


  448. LANG X, Wang DM, Du XD, Jia QF, et al
    Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms.
    Schizophr Res. 2020 May 22. pii: S0920-9964(20)30286.
    PubMed     Abstract available


  449. TAKAHASHI T, Tsugawa S, Nakajima S, Plitman E, et al
    Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30223.
    PubMed     Abstract available


  450. SCORIELS L, Genaro LT, Mororo LGC, Keffer S, et al
    Auditory versus visual neuroscience-informed cognitive training in schizophrenia: Effects on cognition, symptoms and quality of life.
    Schizophr Res. 2020 May 21. pii: S0920-9964(20)30269.
    PubMed     Abstract available


  451. BAYTUNCA BM, Kalyoncu T, Ozbaran B, Kose S, et al
    Reduced blood agmatine level in early-onset schizophrenia.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30258.
    PubMed    


  452. KLINE ER
    Commentary: Expressed emotion as a mechanistic target in psychosis early intervention.
    Schizophr Res. 2020 May 20. pii: S0920-9964(20)30263.
    PubMed    


  453. GRAY R, Shrestha M, Brown E
    Acceptance- and mindfulness-based interventions for persons with psychosis: Potential errors in reported meta-analyses.
    Schizophr Res. 2020 May 19. pii: S0920-9964(20)30273.
    PubMed    


  454. LEI G, Liu F, Liu P, Jiao T, et al
    Does genetic mouse model of constitutive Hint1 deficiency exhibit schizophrenia-like behaviors?
    Schizophr Res. 2020 May 18. pii: S0920-9964(20)30270.
    PubMed     Abstract available


  455. DEAN DJ, Woodward N, Walther S, McHugo M, et al
    Cognitive motor impairments and brain structure in schizophrenia spectrum disorder patients with a history of catatonia.
    Schizophr Res. 2020 May 15. pii: S0920-9964(20)30264.
    PubMed     Abstract available


  456. WANG SP, Wang JD, Chang JH, Wu BJ, et al
    Frailty affects employment outcomes in patients with schizophrenia in noncompetitive employment: A 4-year longitudinal study.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30233.
    PubMed     Abstract available


  457. FORMICA MJC, Phillips LJ, Hartmann JA, Yung AR, et al
    Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30235.
    PubMed     Abstract available


  458. WOODS SW, Bearden CE, Sabb FW, Stone WS, et al
    Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.
    Schizophr Res. 2020 May 10. pii: S0920-9964(20)30227.
    PubMed     Abstract available


  459. KUMARI V, Ettinger U
    Controlled sleep deprivation as an experimental medicine model of schizophrenia: An update.
    Schizophr Res. 2020 May 8. pii: S0920-9964(20)30175.
    PubMed     Abstract available


  460. PILLNY M, Schlier B, Lincoln TM
    "I just don't look forward to anything". How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30170.
    PubMed     Abstract available


  461. MONTAGNESE M, Knolle F, Haarsma J, Griffin JD, et al
    Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population.
    Schizophr Res. 2020 May 7. pii: S0920-9964(20)30229.
    PubMed     Abstract available


  462. BROWN E, Gray R, Lo Monaco S, O'Donoghue B, et al
    The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research.
    Schizophr Res. 2020 May 6. pii: S0920-9964(20)30257.
    PubMed     Abstract available


  463. FRAJMAN A, Maggio N, Muler I, Haroutunian V, et al
    Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia.
    Schizophr Res. 2020 May 3. pii: S0920-9964(20)30234.
    PubMed     Abstract available


    April 2020
  464. DEVOE DJ, Lu L, Cannon TD, Cadenhead KS, et al
    Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
    Schizophr Res. 2020 Apr 30. pii: S0920-9964(20)30211.
    PubMed     Abstract available


  465. YEE N, Matheson S, Korobanova D, Large M, et al
    A meta-analysis of the relationship between psychosis and any type of criminal offending, in both men and women.
    Schizophr Res. 2020 Apr 29. pii: S0920-9964(20)30216.
    PubMed     Abstract available


  466. FROHLICH F, Lustenberger C
    Neuromodulation of sleep rhythms in schizophrenia: Towards the rational design of non-invasive brain stimulation.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30210.
    PubMed     Abstract available


  467. VIOLEAU L, Valery KM, Fournier T, Prouteau A, et al
    How continuum beliefs can reduce stigma of schizophrenia: The role of perceived similarities.
    Schizophr Res. 2020 Apr 27. pii: S0920-9964(20)30221.
    PubMed     Abstract available


  468. OLIVER D, Spada G, Englund A, Chesney E, et al
    Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study.
    Schizophr Res. 2020 Apr 24. pii: S0920-9964(20)30222.
    PubMed     Abstract available


  469. YOLKEN R, Prandovszky E, Severance EG, Hatfield G, et al
    The oropharyngeal microbiome is altered in individuals with schizophrenia and mania.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30113.
    PubMed     Abstract available


  470. KELLY JR, Minuto C, Cryan JF, Clarke G, et al
    The role of the gut microbiome in the development of schizophrenia.
    Schizophr Res. 2020 Apr 23. pii: S0920-9964(20)30086.
    PubMed     Abstract available


  471. SUBOTNIK KL, Ventura J, Hellemann GS, Zito MF, et al
    Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis.
    Schizophr Res. 2020 Apr 22. pii: S0920-9964(20)30148.
    PubMed     Abstract available


  472. VALIENTE-PALLEJA A, Torrell H, Alonso Y, Vilella E, et al
    Increased blood lactate levels during exercise and mitochondrial DNA alterations converge on mitochondrial dysfunction in schizophrenia.
    Schizophr Res. 2020 Apr 21. pii: S0920-9964(20)30181.
    PubMed     Abstract available


  473. LUCKHOFF H, Asmal L, Kilian S, Scheffler F, et al
    Sex versus gender as risk factors for the age of onset of schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 20. pii: S0920-9964(20)30219.
    PubMed    


  474. WATERS F, Chiu VW, Dragovic M, Ree M, et al
    Different patterns of treatment response to Cognitive-Behavioural Therapy for Insomnia (CBT-I) in psychosis.
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30165.
    PubMed     Abstract available


  475. KURTULMUS A, Elbay A, Ozdemir MH
    Response to commentary "Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients".
    Schizophr Res. 2020 Apr 18. pii: S0920-9964(20)30208.
    PubMed    


  476. SHEFFIELD JM, Rogers BP, Blackford JU, Heckers S, et al
    Insula functional connectivity in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30179.
    PubMed     Abstract available


  477. FERNANDEZ-SOTOS P, Garcia-Martinez B, Ricarte JJ, Latorre JM, et al
    Electroencephalographic spectral analysis from a wireless low-cost brain-computer interface for symptom capture of auditory verbal hallucinations in schizophrenia.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30218.
    PubMed    


  478. RABALLO A, Poletti M, Preti A, McGorry P, et al
    Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences.
    Schizophr Res. 2020 Apr 16. pii: S0920-9964(20)30174.
    PubMed     Abstract available


  479. BARRY AB, Koeppel JA, Ho BC
    Impulsive decision making, brain cortical thickness and familial schizophrenia risk.
    Schizophr Res. 2020 Apr 15. pii: S0920-9964(20)30206.
    PubMed     Abstract available


  480. VERNAL DL, Boldsen SK, Lauritsen MB, Correll CU, et al
    Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study.
    Schizophr Res. 2020 Apr 13. pii: S0920-9964(20)30155.
    PubMed     Abstract available


  481. VIHER PV, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Altered diffusion in motor white matter tracts in psychosis patients with catatonia.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30120.
    PubMed     Abstract available


  482. MINICHINO A, Brondino N, Solmi M, Del Giovane C, et al
    The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30101.
    PubMed     Abstract available


  483. QIAN N, Lipkin RM, Kaszowska A, Silipo G, et al
    Computational modeling of excitatory/inhibitory balance impairments in schizophrenia.
    Schizophr Res. 2020 Apr 11. pii: S0920-9964(20)30133.
    PubMed     Abstract available


  484. PAQUIN V, Lemire M, King S
    Ecosystem approaches to the risk for schizophrenia.
    Schizophr Res. 2020 Apr 10. pii: S0920-9964(20)30168.
    PubMed    


  485. CHAN SKW, Chan HYV, Pang HH, Hui CLM, et al
    Ten-year trajectory and outcomes of negative symptoms of patients with first-episode schizophrenia spectrum disorders.
    Schizophr Res. 2020 Apr 8. pii: S0920-9964(20)30172.
    PubMed     Abstract available


  486. PARDO-DE-SANTAYANA G, Vazquez-Bourgon J, Gomez-Revuelta M, Ayesa-Arriola R, et al
    Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study.
    Schizophr Res. 2020 Apr 7. pii: S0920-9964(20)30112.
    PubMed     Abstract available


  487. NAKONEZNY PA, Lindow JC, Stroup TS, McEvoy JP, et al
    A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30164.
    PubMed     Abstract available


  488. YANG LH, Ruiz B, Mandavia AD, Grivel MM, et al
    Advancing study of cognitive impairments for antipsychotic-naive psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.
    Schizophr Res. 2020 Apr 5. pii: S0920-9964(20)30060.
    PubMed     Abstract available


  489. LI XB, Jiang WL, Wen YJ, Wang CM, et al
    The attenuated visual scanpaths of patients with schizophrenia whilst recognizing emotional facial expressions are worsened in natural social scenes.
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30150.
    PubMed     Abstract available


  490. COWAN HR
    Is schizophrenia research relevant during the COVID-19 pandemic?
    Schizophr Res. 2020 Apr 4. pii: S0920-9964(20)30209.
    PubMed     Abstract available


  491. JALLES C, Chendo I, Levy P, Reimao S, et al
    Neuromelanin changes in first episode psychosis with substance abuse.
    Schizophr Res. 2020 Apr 3. pii: S0920-9964(20)30140.
    PubMed    


  492. WYSOKINSKI A
    Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30171.
    PubMed    


  493. PELIZZA L, Poletti M, Azzali S, Paterlini F, et al
    Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study.
    Schizophr Res. 2020 Apr 2. pii: S0920-9964(20)30163.
    PubMed     Abstract available


  494. BANNAI D, Lizano P
    Identifying retinal layer endophenotypes for schizophrenia.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30166.
    PubMed    


  495. XAVIER G, Santoro ML, Ota VK, Spindola LM, et al
    Blood gene expression changes after Risperidone treatment in an antipsychotic-naive cohort of first episode of psychosis patients.
    Schizophr Res. 2020 Apr 1. pii: S0920-9964(20)30139.
    PubMed    


  496. TOROUS J, Keshavan M
    COVID-19, mobile health and serious mental illness.
    Schizophr Res. 2020;218:36-37.
    PubMed    


    March 2020
  497. KIM SJ, Jung DU, Moon JJ, Jeon DW, et al
    Effects of an extrinsic motivator on the evaluation of cognitive and daily living functions in patients with schizophrenia.
    Schizophr Res. 2020 Mar 30. pii: S0920-9964(20)30142.
    PubMed     Abstract available


  498. EGER G, Reuven Y, Dreiher J, Shvartzman P, et al
    Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study.
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30149.
    PubMed     Abstract available


  499. ACOSTA FJ, Navarro S, Cabrera B, Ramallo-Farina Y, et al
    Painful insight vs. usable insight in schizophrenia. Do they have different influences on suicidal behavior?
    Schizophr Res. 2020 Mar 27. pii: S0920-9964(20)30151.
    PubMed     Abstract available


  500. UMEH A, Kumar J, Francis ST, Liddle PF, et al
    Global fMRI signal at rest relates to symptom severity in schizophrenia.
    Schizophr Res. 2020 Mar 25. pii: S0920-9964(20)30141.
    PubMed    


  501. EMSLEY R
    Guest editorial: Special issue on maintenance treatment in schizophrenia.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30135.
    PubMed    


  502. CASTELNOVO A, Zago M, Casetta C, Zangani C, et al
    Slow wave oscillations in Schizophrenia First-Degree Relatives: A confirmatory analysis and feasibility study on slow wave traveling.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30131.
    PubMed     Abstract available


  503. LIANG S, Deng W, Li X, Wang Q, et al
    Aberrant posterior cingulate connectivity classify first-episode schizophrenia from controls: A machine learning study.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30128.
    PubMed     Abstract available


  504. BREBION G, Stephan-Otto C, Cuevas-Esteban J, Usall J, et al
    Impaired memory for temporal context in schizophrenia patients with hallucinations and thought disorganisation.
    Schizophr Res. 2020 Mar 24. pii: S0920-9964(20)30116.
    PubMed     Abstract available


  505. RANGASWAMY T, Cohen A
    Invited commentary from a LAMIC country: Thirty-five years of schizophrenia - the Madras Longitudinal study.
    Schizophr Res. 2020 Mar 23. pii: S0920-9964(20)30132.
    PubMed    


    January 2020
  506. VELLIGAN DI, Maples NJ, Pokorny JJ, Wright C, et al
    Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Schizophr Res. 2020;215:17-24.
    PubMed     Abstract available


  507. BLESS JJ, Hjelmervik H, Torsheim T, Gudmundsen M, et al
    Temporal signatures of auditory verbal hallucinations: An app-based experience sampling study.
    Schizophr Res. 2020;215:442-444.
    PubMed    


  508. SPOOV J, Bredbacka PE, Stenman UH
    Separation of positive and disorganization symptoms by prolactin response to 12.5 mug intravenous TRH.
    Schizophr Res. 2020;215:449-450.
    PubMed    


  509. VOSTRIKOV VM, Uranova NA
    Reduced density of oligodendrocytes and oligodendrocyte clusters in the caudate nucleus in major psychiatric illnesses.
    Schizophr Res. 2020;215:211-216.
    PubMed     Abstract available


  510. HAJDUK M, Achim AM, Brunet-Gouet E, Mehta UM, et al
    How to move forward in social cognition research? Put it into an international perspective.
    Schizophr Res. 2020;215:463-464.
    PubMed    


  511. HARVEY PD, Saoud JB, Luthringer R, Moroz S, et al
    Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression.
    Schizophr Res. 2020;215:352-356.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: